I am trained in Internal Medicine, with additional training in clinical research methods, biostatistics, and behavioral medicine. My research focus for many years was on HIV. I developed one of the largest cohorts in the world of persons followed from primary HIV (within 6 months of infection), the Options Project, in which we have examined clinical, behavioral, cardiovascular, and immunologic research questions. In 2002, I became Director of Research at the UCSF Osher Center for Integrative Medicine. My research is driven by the belief that modern medicine has made impressive advances in treating a range of health conditions, but that further advances for many of the most important health problems of our era, including obesity, diabetes, heart disease, and mental health issues require improved development and implementation of lifestyle and other non-pharmacologic approaches. An important goal of my research program is to rigorously test whether we can improve interventions for chronic health problems such as HIV, diabetes, obesity, and stress, by incorporating mindfulness and/or yoga-based components. A current example is an NIH-funded study to test whether including training in mindful eating practices decreases eating in response to food cravings and enhances adherence to a nutritional plan in type 2 diabetes. I bring a focus on clinical research methodology to the projects I am involved with. I am particularly interested in the use of innovative research methodology to strengthen the rigor of research on nonpharmacolgic health interventions, including factorial trials and Sequential Multiple Assignment Randomized Trials (SMARTs), and assessment of teacher factors in mindfulness programs to improve intervention fidelity . In my role as Director of the UCSF Osher Center Research Program, I have played a key leadership role in building it into an internationally recognized integrative medicine research center that is distinguished by the application of innovative and rigorous research designs to studying mindfulness-based interventions, yoga, acupuncture, interoceptive awareness, and behavioral interventions. I have served in a variety of leadership roles in HIV medicine and integrative health, including as board chair of the Academic Consortium for Integrative Medicine and Health, which gives me a broad view of the field. I have a strong commitment to mentoring. I have led UCSF’s highly successful Training Research in Integrative Medicine (TRIM) fellowship program since 2006, and have served as a primary or main co-mentor for 12 NIH K awardees. I have served as PI or co-PI/project director for 31 grants, 19 of them from NIH, including leading three Program Project grants.
Antar AA, Jenike KM, Jang S, Rigau DN, Reeves DB, Hoh R, Krone MR, Keruly JC, Moore RD, Schiffer JT, Nonyane BA, Hecht FM, Deeks SG, Siliciano JD, Ho YC, Siliciano RF
Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy. J Clin Invest. 2020 07 01; 130(7):3543-3559.
Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy.
Li Y, Altan E, Pilcher C, Hartogensis W, Hecht FM, Deng X, Delwart E
Semen virome of men with HIV on or off antiretroviral treatment. AIDS. 2020 05 01; 34(6):827-832.
Semen virome of men with HIV on or off antiretroviral treatment.
Daubenmier J, Epel ES, Moran PJ, Thompson J, Mason AE, Acree M, Goldman V, Kristeller J, Hecht FM, Mendes WB
A Randomized Controlled Trial of a Mindfulness-Based Weight Loss Intervention on Cardiovascular Reactivity to Social-Evaluative Threat Among Adults with Obesity. Mindfulness (N Y). 2019 Dec; 10(12):2583-2595.
A Randomized Controlled Trial of a Mindfulness-Based Weight Loss Intervention on Cardiovascular Reactivity to Social-Evaluative Threat Among Adults with Obesity.
Scharf L, Tauriainen J, Buggert M, Hartogensis W, Nolan DJ, Deeks SG, Salemi M, Hecht FM, Karlsson AC
Delayed Expression of PD-1 and TIGIT on HIV-Specific CD8 T Cells in Untreated HLA-B*57:01 Individuals Followed from Early Infection. J Virol. 2020 07 01; 94(14).
Delayed Expression of PD-1 and TIGIT on HIV-Specific CD8 T Cells in Untreated HLA-B*57:01 Individuals Followed from Early Infection.
Liu R, Santana T, Schillinger D, Hecht FM, Chao MT
"It Gave Me Hope" Experiences of Diverse Safety Net Patients in a Group Acupuncture Intervention for Painful Diabetic Neuropathy. Health Equity. 2020; 4(1):225-231.
"It Gave Me Hope" Experiences of Diverse Safety Net Patients in a Group Acupuncture Intervention for Painful Diabetic Neuropathy.
Training Researchers in Clinical Integrative Medicine (TRIM)
Predictors of Outcomes in MBSR Participants from Teacher Factors
DARE: Delaney AIDS Research Enterprise to find a cure.
Optimizing lifestyle interventions with mindfulness-based strategies in type 2 diabetes
2016 International Congress on Integrative Medicine and Health
Mascarenhas MN, Chan JM, Vittinghoff E, Van Blarigan EL, Hecht F
Increasing Physical Activity in Mothers Using Video Exercise Groups and Exercise Mobile Apps: Randomized Controlled Trial. J Med Internet Res. 2018 05 18; 20(5):e179.
Increasing Physical Activity in Mothers Using Video Exercise Groups and Exercise Mobile Apps: Randomized Controlled Trial.
Metabolic and Immunologic Effects of Meditation
Mentoring and Research in Integrative Medicine
MBSR, Stress Arousal and Immune Response in Early HIV
Spudich S, Gisslen M, Hagberg L, Lee E, Liegler T, Brew B, Fuchs D, Tambussi G, Cinque P, Hecht FM, Price RW
Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis. 2011 Sep 01; 204(5):753-60.
Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.
Daubenmier J, Kristeller J, Hecht FM, Maninger N, Kuwata M, Jhaveri K, Lustig RH, Kemeny M, Karan L, Epel E
Mindfulness Intervention for Stress Eating to Reduce Cortisol and Abdominal Fat among Overweight and Obese Women: An Exploratory Randomized Controlled Study. J Obes. 2011; 2011:651936.
Mindfulness Intervention for Stress Eating to Reduce Cortisol and Abdominal Fat among Overweight and Obese Women: An Exploratory Randomized Controlled Study.
Eriksson EM, Milush JM, Ho EL, Batista MD, Holditch SJ, Keh CE, Norris PJ, Keating SM, Deeks SG, Hunt PW, Martin JN, Rosenberg MG, Hecht FM, Nixon DF
Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity. Blood. 2012 Jan 19; 119(3):745-55.
Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity.
Daubenmier J, Lin J, Blackburn E, Hecht FM, Kristeller J, Maninger N, Kuwata M, Bacchetti P, Havel PJ, Epel E
Changes in stress, eating, and metabolic factors are related to changes in telomerase activity in a randomized mindfulness intervention pilot study. Psychoneuroendocrinology. 2012 Jul; 37(7):917-28.
Changes in stress, eating, and metabolic factors are related to changes in telomerase activity in a randomized mindfulness intervention pilot study.
Mehling WE, Lown EA, Dvorak CC, Cowan MJ, Horn BN, Dunn EA, Acree M, Abrams DI, Hecht FM
Evidence-based complementary and alternative medicine : eCAM
Hematopoietic cell transplant and use of massage for improved symptom management: results from a pilot randomized control trial. Evid Based Complement Alternat Med. 2012; 2012:450150.
Hematopoietic cell transplant and use of massage for improved symptom management: results from a pilot randomized control trial.
Dhruva A, Miaskowski C, Abrams D, Acree M, Cooper B, Goodman S, Hecht FM
Journal of alternative and complementary medicine (New York, N.Y.)
Yoga breathing for cancer chemotherapy-associated symptoms and quality of life: results of a pilot randomized controlled trial. J Altern Complement Med. 2012 May; 18(5):473-9.
Yoga breathing for cancer chemotherapy-associated symptoms and quality of life: results of a pilot randomized controlled trial.
Ho JE, Scherzer R, Hecht FM, Maka K, Selby V, Martin JN, Ganz P, Deeks SG, Hsue PY
The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease. AIDS. 2012 Jun 01; 26(9):1115-20.
The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease.
Gurfein BT, Stamm AW, Bacchetti P, Dallman MF, Nadkarni NA, Milush JM, Touma C, Palme R, Di Borgo CP, Fromentin G, Lown-Hecht R, Konsman JP, Acree M, Premenko-Lanier M, Darcel N, Hecht FM, Nixon DF
The calm mouse: an animal model of stress reduction. Mol Med. 2012 May 09; 18:606-17.
The calm mouse: an animal model of stress reduction.
Mehling WE, Gopisetty V, Bartmess E, Acree M, Pressman A, Goldberg H, Hecht FM, Carey T, Avins AL
The prognosis of acute low back pain in primary care in the United States: a 2-year prospective cohort study. Spine (Phila Pa 1976). 2012 Apr 15; 37(8):678-84.
The prognosis of acute low back pain in primary care in the United States: a 2-year prospective cohort study.
Josefsson L, Eriksson S, Sinclair E, Ho T, Killian M, Epling L, Shao W, Lewis B, Bacchetti P, Loeb L, Custer J, Poole L, Hecht FM, Palmer S
Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNA. J Infect Dis. 2012 Jul 01; 206(1):28-34.
Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNA.
Norström MM, Buggert M, Tauriainen J, Hartogensis W, Prosperi MC, Wallet MA, Hecht FM, Salemi M, Karlsson AC
Combination of immune and viral factors distinguishes low-risk versus high-risk HIV-1 disease progression in HLA-B*5701 subjects. J Virol. 2012 Sep; 86(18):9802-16.
Combination of immune and viral factors distinguishes low-risk versus high-risk HIV-1 disease progression in HLA-B*5701 subjects.
Champiat S, Raposo RA, Maness NJ, Lehman JL, Purtell SE, Hasenkrug AM, Miller JC, Dean H, Koff WC, Hong MA, Martin JN, Deeks SG, Spotts GE, Pilcher CD, Hecht FM, Kallas EG, Garrison KE, Nixon DF
Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection. PLoS One. 2012; 7(6):e39311.
Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection.
Hatano H, Jain V, Hunt PW, Lee TH, Sinclair E, Do TD, Hoh R, Martin JN, McCune JM, Hecht F, Busch MP, Deeks SG
Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. J Infect Dis. 2013 Jul; 208(1):50-6.
Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells.
Perez CL, Milush JM, Buggert M, Eriksson EM, Larsen MV, Liegler T, Hartogensis W, Bacchetti P, Lund O, Hecht FM, Nixon DF, Karlsson AC
Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletion. AIDS Res Hum Retroviruses. 2013 Mar; 29(3):602-12.
Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletion.
Eriksson EM, Keh CE, Deeks SG, Martin JN, Hecht FM, Nixon DF
Differential expression of CD96 surface molecule represents CD8⁺ T cells with dissimilar effector function during HIV-1 infection. PLoS One. 2012; 7(12):e51696.
Differential expression of CD96 surface molecule represents CD8⁺ T cells with dissimilar effector function during HIV-1 infection.
Vallabhaneni S, McConnell JJ, Loeb L, Hartogensis W, Hecht FM, Grant RM, Pilcher CD
Changes in seroadaptive practices from before to after diagnosis of recent HIV infection among men who have sex with men. PLoS One. 2013; 8(2):e55397.
Changes in seroadaptive practices from before to after diagnosis of recent HIV infection among men who have sex with men.
Smith SD, Morgan R, Link MP, McFall P, Hecht F
Cytogenetic and immunophenotypic analysis of cell lines established from patients with T cell leukemia/lymphoma. Blood. 1986 Mar; 67(3):650-6.
Cytogenetic and immunophenotypic analysis of cell lines established from patients with T cell leukemia/lymphoma.
Eriksson S, Graf EH, Dahl V, Strain MC, Yukl SA, Lysenko ES, Bosch RJ, Lai J, Chioma S, Emad F, Abdel-Mohsen M, Hoh R, Hecht F, Hunt P, Somsouk M, Wong J, Johnston R, Siliciano RF, Richman DD, O'Doherty U, Palmer S, Deeks SG, Siliciano JD
Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog. 2013 Feb; 9(2):e1003174.
Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies.
Champiat S, Garrison KE, Raposo RA, Burwitz BJ, Reed J, Tandon R, York VA, Newman LP, Nimityongskul FA, Wilson NA, Almeida RR, Martin JN, Deeks SG, Rosenberg MG, Wiznia AA, Spotts GE, Pilcher CD, Hecht FM, Ostrowski MA, Sacha JB, Nixon DF
T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques. J Virol. 2013 Jun; 87(11):6073-80.
T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques.
Jain V, Hartogensis W, Bacchetti P, Hunt PW, Hatano H, Sinclair E, Epling L, Lee TH, Busch MP, McCune JM, Pilcher CD, Hecht FM, Deeks SG
Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis. 2013 Oct 15; 208(8):1202-11.
Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.
Patterson S, Moran P, Epel E, Sinclair E, Kemeny ME, Deeks SG, Bacchetti P, Acree M, Epling L, Kirschbaum C, Hecht FM
Cortisol patterns are associated with T cell activation in HIV. PLoS One. 2013; 8(7):e63429.
Cortisol patterns are associated with T cell activation in HIV.
Ooms M, Brayton B, Letko M, Maio SM, Pilcher CD, Hecht FM, Barbour JD, Simon V
HIV-1 Vif adaptation to human APOBEC3H haplotypes. Cell Host Microbe. 2013 Oct 16; 14(4):411-21.
HIV-1 Vif adaptation to human APOBEC3H haplotypes.
Crawford TQ, Hecht FM, Pilcher CD, Ndhlovu LC, Barbour JD
Activation associated ERK1/2 signaling impairments in CD8+ T cells co-localize with blunted polyclonal and HIV-1 specific effector functions in early untreated HIV-1 infection. PLoS One. 2013; 8(10):e77412.
Activation associated ERK1/2 signaling impairments in CD8+ T cells co-localize with blunted polyclonal and HIV-1 specific effector functions in early untreated HIV-1 infection.
Vaidya SA, Streeck H, Beckwith N, Ghebremichael M, Pereyra F, Kwon DS, Addo MM, Rychert J, Routy JP, Jessen H, Kelleher AD, Hecht F, Sekaly RP, Carrington M, Walker BD, Allen TM, Rosenberg ES, Altfeld M
Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection. Retrovirology. 2013 Nov 18; 10:139.
Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection.
Josefsson L, von Stockenstrom S, Faria NR, Sinclair E, Bacchetti P, Killian M, Epling L, Tan A, Ho T, Lemey P, Shao W, Hunt PW, Somsouk M, Wylie W, Douek DC, Loeb L, Custer J, Hoh R, Poole L, Deeks SG, Hecht F, Palmer S
Proceedings of the National Academy of Sciences of the United States of America
The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time. Proc Natl Acad Sci U S A. 2013 Dec 17; 110(51):E4987-96.
The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time.
Daubenmier J, Lustig RH, Hecht FM, Kristeller J, Woolley J, Adam T, Dallman M, Epel E
A new biomarker of hedonic eating? A preliminary investigation of cortisol and nausea responses to acute opioid blockade. Appetite. 2014 Mar; 74:92-100.
A new biomarker of hedonic eating? A preliminary investigation of cortisol and nausea responses to acute opioid blockade.
Pilcher CD, Louie B, Facente S, Keating S, Hackett J, Vallari A, Hall C, Dowling T, Busch MP, Klausner JD, Hecht FM, Liska S, Pandori MW
Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco. PLoS One. 2013; 8(12):e80629.
Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco.
Milush JM, López-Vergès S, York VA, Deeks SG, Martin JN, Hecht FM, Lanier LL, Nixon DF
CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection. Retrovirology. 2013 Dec 18; 10:158.
CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection.
Gold JA, Grill M, Peterson J, Pilcher C, Lee E, Hecht FM, Fuchs D, Yiannoutsos CT, Price RW, Robertson K, Spudich S
Longitudinal characterization of depression and mood states beginning in primary HIV infection. AIDS Behav. 2014 Jun; 18(6):1124-32.
Longitudinal characterization of depression and mood states beginning in primary HIV infection.
Dhruva A, Hecht FM, Miaskowski C, Kaptchuk TJ, Bodeker G, Abrams D, Lad V, Adler SR
Correlating traditional Ayurvedic and modern medical perspectives on cancer: results of a qualitative study. J Altern Complement Med. 2014 May; 20(5):364-70.
Correlating traditional Ayurvedic and modern medical perspectives on cancer: results of a qualitative study.
Michaud HA, de Mulder M, SenGupta D, Deeks SG, Martin JN, Pilcher CD, Hecht FM, Sacha JB, Nixon DF
Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection. Retrovirology. 2014 Jan 28; 11:10.
Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.
Lee SA, Sinclair E, Hatano H, Hsue PY, Epling L, Hecht FM, Bangsberg DR, Martin JN, McCune JM, Deeks SG, Hunt PW
Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging. PLoS One. 2014; 9(2):e89444.
Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging.
Lee SA, Sinclair E, Jain V, Huang Y, Epling L, Van Natta M, Meinert CL, Martin JN, McCune JM, Deeks SG, Lederman MM, Hecht FM, Hunt PW
Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection. J Infect Dis. 2014 Aug 01; 210(3):374-82.
Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection.
The quality and influence of JAMA. JAMA. 1988 Apr 01; 259(13):1946-7.
Gurfein BT, Davidenko O, Premenko-Lanier M, Milush JM, Acree M, Dallman MF, Touma C, Palme R, York VA, Fromentin G, Darcel N, Nixon DF, Hecht FM
Environmental enrichment alters splenic immune cell composition and enhances secondary influenza vaccine responses in mice. Mol Med. 2014 Apr 22; 20:179-90.
Environmental enrichment alters splenic immune cell composition and enhances secondary influenza vaccine responses in mice.
Saslow LR, Kim S, Daubenmier JJ, Moskowitz JT, Phinney SD, Goldman V, Murphy EJ, Cox RM, Moran P, Hecht FM
A randomized pilot trial of a moderate carbohydrate diet compared to a very low carbohydrate diet in overweight or obese individuals with type 2 diabetes mellitus or prediabetes. PLoS One. 2014; 9(4):e91027.
A randomized pilot trial of a moderate carbohydrate diet compared to a very low carbohydrate diet in overweight or obese individuals with type 2 diabetes mellitus or prediabetes.
Buggert M, Norström MM, Salemi M, Hecht FM, Karlsson AC
Journal of immunology (Baltimore, Md. : 1950)
Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progression. J Immunol. 2014 May 15; 192(10):4685-96.
Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progression.
Wang C, Abdel-Mohsen M, Strain MC, Lada SM, Yukl S, Cockerham LR, Pilcher CD, Hecht FM, Sinclair E, Liegler T, Richman DD, Deeks SG, Pillai SK
Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy. J Infect Dis. 2014 Dec 01; 210(11):1838-43.
Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy.
Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, Ferre AL, Hayes TL, Somsouk M, Hsue PY, Van Natta ML, Meinert CL, Lederman MM, Hatano H, Jain V, Huang Y, Hecht FM, Martin JN, McCune JM, Moreno S, Deeks SG
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog. 2014 May; 10(5):e1004078.
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.
Cockerham LR, Jain V, Sinclair E, Glidden DV, Hartogenesis W, Hatano H, Hunt PW, Martin JN, Pilcher CD, Sekaly R, McCune JM, Hecht FM, Deeks SG
Programmed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV disease. AIDS. 2014 Jul 31; 28(12):1749-58.
Programmed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV disease.
McDermott KA, Rao MR, Nagarathna R, Murphy EJ, Burke A, Nagendra RH, Hecht FM
BMC complementary and alternative medicine
A yoga intervention for type 2 diabetes risk reduction: a pilot randomized controlled trial. BMC Complement Altern Med. 2014 Jul 01; 14:212.
A yoga intervention for type 2 diabetes risk reduction: a pilot randomized controlled trial.
Raposo RA, Abdel-Mohsen M, Deng X, Hecht FM, Pilcher CD, Pillai SK, Nixon DF
Dynamic regulation of host restriction factor expression over the course of HIV-1 infection in vivo. J Virol. 2014 Oct; 88(19):11624-9.
Dynamic regulation of host restriction factor expression over the course of HIV-1 infection in vivo.
Swanson G, Picozzi V, Morgan R, Hecht F, Greenberg P
Responses of hemopoietic precursors to 13-cis retinoic acid and 1,25 dihydroxyvitamin D3 in the myelodysplastic syndromes. Blood. 1986 Apr; 67(4):1154-61.
Responses of hemopoietic precursors to 13-cis retinoic acid and 1,25 dihydroxyvitamin D3 in the myelodysplastic syndromes.
Streeck H, Lu R, Beckwith N, Milazzo M, Liu M, Routy JP, Little S, Jessen H, Kelleher AD, Hecht F, Sekaly RP, Alter G, Heckerman D, Carrington M, Rosenberg ES, Altfeld M
Emergence of individual HIV-specific CD8 T cell responses during primary HIV-1 infection can determine long-term disease outcome. J Virol. 2014 Nov; 88(21):12793-801.
Emergence of individual HIV-specific CD8 T cell responses during primary HIV-1 infection can determine long-term disease outcome.
Norström MM, Veras NM, Huang W, Proper MC, Cook J, Hartogensis W, Hecht FM, Karlsson AC, Karlsoon AC, Salemi M
Baseline CD4+ T cell counts correlates with HIV-1 synonymous rate in HLA-B*5701 subjects with different risk of disease progression. PLoS Comput Biol. 2014 Sep; 10(9):e1003830.
Baseline CD4+ T cell counts correlates with HIV-1 synonymous rate in HLA-B*5701 subjects with different risk of disease progression.
Henje Blom E, Duncan LG, Ho TC, Connolly CG, LeWinn KZ, Chesney M, Hecht FM, Yang TT
The development of an RDoC-based treatment program for adolescent depression: "Training for Awareness, Resilience, and Action" (TARA). Front Hum Neurosci. 2014; 8:630.
The development of an RDoC-based treatment program for adolescent depression: "Training for Awareness, Resilience, and Action" (TARA).
Kassanjee R, Pilcher CD, Keating SM, Facente SN, McKinney E, Price MA, Martin JN, Little S, Hecht FM, Kallas EG, Welte A, Busch MP, Murphy G, Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA)
Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS. 2014 Oct 23; 28(16):2439-49.
Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository.
Klatt NR, Bosinger SE, Peck M, Richert-Spuhler LE, Heigele A, Gile JP, Patel N, Taaffe J, Julg B, Camerini D, Torti C, Martin JN, Deeks SG, Sinclair E, Hecht FM, Lederman MM, Paiardini M, Kirchhoff F, Brenchley JM, Hunt PW, Silvestri G
Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals. PLoS Pathog. 2014 Aug; 10(8):e1004345.
Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals.
Cockerham LR, Siliciano JD, Sinclair E, O'Doherty U, Palmer S, Yukl SA, Strain MC, Chomont N, Hecht FM, Siliciano RF, Richman DD, Deeks SG
CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells. PLoS One. 2014; 9(10):e110731.
CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells.
Mehling WE, Avins AL, Acree MC, Carey TS, Hecht FM
European journal of pain (London, England)
Can a back pain screening tool help classify patients with acute pain into risk levels for chronic pain? Eur J Pain. 2015 Mar; 19(3):439-46.
Can a back pain screening tool help classify patients with acute pain into risk levels for chronic pain?
Prather AA, Gurfein B, Moran P, Daubenmier J, Acree M, Bacchetti P, Sinclair E, Lin J, Blackburn E, Hecht FM, Epel ES
Tired telomeres: Poor global sleep quality, perceived stress, and telomere length in immune cell subsets in obese men and women. Brain Behav Immun. 2015 Jul; 47:155-62.
Tired telomeres: Poor global sleep quality, perceived stress, and telomere length in immune cell subsets in obese men and women.
Hollingsworth TD, Pilcher CD, Hecht FM, Deeks SG, Fraser C
High Transmissibility During Early HIV Infection Among Men Who Have Sex With Men-San Francisco, California. J Infect Dis. 2015 Jun 01; 211(11):1757-60.
High Transmissibility During Early HIV Infection Among Men Who Have Sex With Men-San Francisco, California.
Abdel-Mohsen M, Wang C, Strain MC, Lada SM, Deng X, Cockerham LR, Pilcher CD, Hecht FM, Liegler T, Richman DD, Deeks SG, Pillai SK
Select host restriction factors are associated with HIV persistence during antiretroviral therapy. AIDS. 2015 Feb 20; 29(4):411-20.
Select host restriction factors are associated with HIV persistence during antiretroviral therapy.
Kumar D, McDermott K, Feng H, Goldman V, Luke A, Souza RB, Hecht FM
PM & R : the journal of injury, function, and rehabilitation
Effects of Form-Focused Training on Running Biomechanics: A Pilot Randomized Trial in Untrained Individuals. PM R. 2015 Aug; 7(8):814-822.
Effects of Form-Focused Training on Running Biomechanics: A Pilot Randomized Trial in Untrained Individuals.
von Stockenstrom S, Odevall L, Lee E, Sinclair E, Bacchetti P, Killian M, Epling L, Shao W, Hoh R, Ho T, Faria NR, Lemey P, Albert J, Hunt P, Loeb L, Pilcher C, Poole L, Hatano H, Somsouk M, Douek D, Boritz E, Deeks SG, Hecht FM, Palmer S
Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy. J Infect Dis. 2015 Aug 15; 212(4):596-607.
Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy.
Mehling WE, Ebell MH, Avins AL, Hecht FM
The spine journal : official journal of the North American Spine Society
Clinical decision rule for primary care patient with acute low back pain at risk of developing chronic pain. Spine J. 2015 Jul 01; 15(7):1577-86.
Clinical decision rule for primary care patient with acute low back pain at risk of developing chronic pain.
Mason AE, Lustig RH, Brown RR, Acree M, Bacchetti P, Moran PJ, Dallman M, Laraia B, Adler N, Hecht FM, Daubenmier J, Epel ES
Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial. Appetite. 2015 Aug; 91:311-320.
Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial.
Eriksson EM, Liegler T, Keh CE, Karlsson AC, Holditch SJ, Pilcher CD, Loeb L, Nixon DF, Hecht FM
Newly Exerted T Cell Pressures on Mutated Epitopes following Transmission Help Maintain Consensus HIV-1 Sequences. PLoS One. 2014; 10(4):e0120787.
Newly Exerted T Cell Pressures on Mutated Epitopes following Transmission Help Maintain Consensus HIV-1 Sequences.
Mason AE, Laraia B, Daubenmier J, Hecht FM, Lustig RH, Puterman E, Adler N, Dallman M, Kiernan M, Gearhardt AN, Epel ES
Putting the brakes on the "drive to eat": Pilot effects of naltrexone and reward-based eating on food cravings among obese women. Eat Behav. 2015 Dec; 19:53-6.
Putting the brakes on the "drive to eat": Pilot effects of naltrexone and reward-based eating on food cravings among obese women.
Liu E, Hjelle B, Morgan R, Hecht F, Bishop JM
Mutations of the Kirsten-ras proto-oncogene in human preleukaemia. Nature. 1987 Nov 12-18; 330(6144):186-8.
Mutations of the Kirsten-ras proto-oncogene in human preleukaemia.
Moskowitz JT, Duncan LG, Moran PJ, Acree M, Epel ES, Kemeny ME, Hecht FM, Folkman S
Dispositional Mindfulness in People with HIV: Associations with Psychological and Physical Health. Pers Individ Dif. 2015 Nov 01; 86:88-93.
Dispositional Mindfulness in People with HIV: Associations with Psychological and Physical Health.
Gornalusse GG, Mummidi S, Gaitan AA, Jimenez F, Ramsuran V, Picton A, Rogers K, Manoharan MS, Avadhanam N, Murthy KK, Martinez H, Molano Murillo A, Chykarenko ZA, Hutt R, Daskalakis D, Shostakovich-Koretskaya L, Abdool Karim S, Martin JN, Deeks SG, Hecht F, Sinclair E, Clark RA, Okulicz J, Valentine FT, Martinson N, Tiemessen CT, Ndung'u T, Hunt PW, He W, Ahuja SK
Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor. Proc Natl Acad Sci U S A. 2015 Aug 25; 112(34):E4762-71.
Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor.
Procopio FA, Fromentin R, Kulpa DA, Brehm JH, Bebin AG, Strain MC, Richman DD, O'Doherty U, Palmer S, Hecht FM, Hoh R, Barnard RJ, Miller MD, Hazuda DJ, Deeks SG, Sékaly RP, Chomont N
A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals. EBioMedicine. 2015 Aug; 2(8):874-83.
A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.
McDermott K, Kumar D, Goldman V, Feng H, Mehling W, Moskowitz JT, Souza RB, Hecht FM
Training in ChiRunning to reduce blood pressure: a randomized controlled pilot study. BMC Complement Altern Med. 2015 Oct 15; 15:368.
Training in ChiRunning to reduce blood pressure: a randomized controlled pilot study.
Smith SD, Link MP, Trela M, Amylon M, Sklar J, Morgan R, Hecht F
Chromosome 9 abnormalities in childhood T-cell leukemia. N Engl J Med. 1986 Jul 17; 315(3):195-6.
Chromosome 9 abnormalities in childhood T-cell leukemia.
Liu R, Chang A, Reddy S, Hecht FM, Chao MT
Improving Patient-Centered Care: A Cross-Sectional Survey of Prior Use and Interest in Complementary and Integrative Health Approaches Among Hospitalized Oncology Patients. J Altern Complement Med. 2016 Feb; 22(2):160-5.
Improving Patient-Centered Care: A Cross-Sectional Survey of Prior Use and Interest in Complementary and Integrative Health Approaches Among Hospitalized Oncology Patients.
The American journal of pediatric hematology/oncology
Chromosome changes connect immunodeficiency and cancer in ataxia-telangiectasia. Am J Pediatr Hematol Oncol. 1987; 9(2):185-8.
Chromosome changes connect immunodeficiency and cancer in ataxia-telangiectasia.
Chew GM, Fujita T, Webb GM, Burwitz BJ, Wu HL, Reed JS, Hammond KB, Clayton KL, Ishii N, Abdel-Mohsen M, Liegler T, Mitchell BI, Hecht FM, Ostrowski M, Shikuma CM, Hansen SG, Maurer M, Korman AJ, Deeks SG, Sacha JB, Ndhlovu LC
TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection. PLoS Pathog. 2016 Jan; 12(1):e1005349.
TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection.
Whittle HJ, Palar K, Napoles T, Hufstedler LL, Ching I, Hecht FM, Frongillo EA, Weiser SD
Journal of the International AIDS Society
Experiences with food insecurity and risky sex among low-income people living with HIV/AIDS in a resource-rich setting. J Int AIDS Soc. 2015; 18:20293.
Experiences with food insecurity and risky sex among low-income people living with HIV/AIDS in a resource-rich setting.
Pilcher CD, Bisol CA, Paganella MP, Vallabhaneni S, da Motta LR, Kato SK, Sperhacke RD, Kallas EG, Hecht FM, Diaz RS
Efficient Identification of HIV Serodiscordant Couples by Existing HIV Testing Programs in South Brazil. PLoS One. 2015; 10(11):e0142638.
Efficient Identification of HIV Serodiscordant Couples by Existing HIV Testing Programs in South Brazil.
Mason AE, Epel ES, Kristeller J, Moran PJ, Dallman M, Lustig RH, Acree M, Bacchetti P, Laraia BA, Hecht FM, Daubenmier J
Effects of a mindfulness-based intervention on mindful eating, sweets consumption, and fasting glucose levels in obese adults: data from the SHINE randomized controlled trial. J Behav Med. 2016 Apr; 39(2):201-13.
Effects of a mindfulness-based intervention on mindful eating, sweets consumption, and fasting glucose levels in obese adults: data from the SHINE randomized controlled trial.
Vujkovic-Cvijin I, Swainson LA, Chu SN, Ortiz AM, Santee CA, Petriello A, Dunham RM, Fadrosh DW, Lin DL, Faruqi AA, Huang Y, Apetrei C, Pandrea I, Hecht FM, Pilcher CD, Klatt NR, Brenchley JM, Lynch SV, McCune JM
Gut-Resident Lactobacillus Abundance Associates with IDO1 Inhibition and Th17 Dynamics in SIV-Infected Macaques. Cell Rep. 2015 Nov 24; 13(8):1589-97.
Gut-Resident Lactobacillus Abundance Associates with IDO1 Inhibition and Th17 Dynamics in SIV-Infected Macaques.
Stuempfle KJ, Valentino T, Hew-Butler T, Hecht FM, Hoffman MD
Nausea is associated with endotoxemia during a 161-km ultramarathon. J Sports Sci. 2016 Sep; 34(17):1662-8.
Nausea is associated with endotoxemia during a 161-km ultramarathon.
Khoury G, Anderson JL, Fromentin R, Hartogenesis W, Smith MZ, Bacchetti P, Hecht FM, Chomont N, Cameron PU, Deeks SG, Lewin SR
Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy. AIDS. 2016 06 19; 30(10):1511-20.
Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy.
Counseling the HIV-positive woman regarding pregnancy. JAMA. 1987 Jun 26; 257(24):3361.
Counseling the HIV-positive woman regarding pregnancy.
Factors related to telomere length. Brain Behav Immun. 2016 Mar; 53:279.
Ramirez CM, Sinclair E, Epling L, Lee SA, Jain V, Hsue PY, Hatano H, Conn D, Hecht FM, Martin JN, McCune JM, Deeks SG, Hunt PW
Immunologic profiles distinguish aviremic HIV-infected adults. AIDS. 2016 06 19; 30(10):1553-62.
Immunologic profiles distinguish aviremic HIV-infected adults.
Gega A, Kozal MJ, Chiarella J, Lee E, Peterson J, Hecht FM, Liegler T, St John EP, Simen BB, Price RW, Spudich SS
Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection. J Virus Erad. 2015; 1(4):264-268.
Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection.
Daubenmier J, Moran PJ, Kristeller J, Acree M, Bacchetti P, Kemeny ME, Dallman M, Lustig RH, Grunfeld C, Nixon DF, Milush JM, Goldman V, Laraia B, Laugero KD, Woodhouse L, Epel ES, Hecht FM
Effects of a mindfulness-based weight loss intervention in adults with obesity: A randomized clinical trial. Obesity (Silver Spring). 2016 Apr; 24(4):794-804.
Effects of a mindfulness-based weight loss intervention in adults with obesity: A randomized clinical trial.
Mason AE, Epel ES, Aschbacher K, Lustig RH, Acree M, Kristeller J, Cohn M, Dallman M, Moran PJ, Bacchetti P, Laraia B, Hecht FM, Daubenmier J
Reduced reward-driven eating accounts for the impact of a mindfulness-based diet and exercise intervention on weight loss: Data from the SHINE randomized controlled trial. Appetite. 2016 May 01; 100:86-93.
Reduced reward-driven eating accounts for the impact of a mindfulness-based diet and exercise intervention on weight loss: Data from the SHINE randomized controlled trial.
Chao MT, Chang A, Reddy S, Harrison JD, Acquah J, Toveg M, Santana T, Hecht FM
Adjunctive acupuncture for pain and symptom management in the inpatient setting: protocol for a pilot hybrid effectiveness-implementation study. J Integr Med. 2016 May; 14(3):228-38.
Adjunctive acupuncture for pain and symptom management in the inpatient setting: protocol for a pilot hybrid effectiveness-implementation study.
Morgan R, Hecht BK, Sandberg AA, Hecht F, Smith SD
Chromosome 5q35 breakpoint in malignant histiocytosis. N Engl J Med. 1986 May 15; 314(20):1322.
Chromosome 5q35 breakpoint in malignant histiocytosis.
Fromentin R, Bakeman W, Lawani MB, Khoury G, Hartogensis W, DaFonseca S, Killian M, Epling L, Hoh R, Sinclair E, Hecht FM, Bacchetti P, Deeks SG, Lewin SR, Sékaly RP, Chomont N
CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. PLoS Pathog. 2016 07; 12(7):e1005761.
CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.
Willberg CB, Garrison KE, Jones RB, Meiklejohn DA, Spotts G, Liegler TJ, Ostrowski MA, Karlsson AC, Hecht FM, Nixon DF
Correction: Rapid Progressing Allele HLA-B35 Px Restricted Anti-HIV-1 CD8+ T Cells Recognize Vestigial CTL Epitopes. PLoS One. 2016; 11(7):e0160293.
Correction: Rapid Progressing Allele HLA-B35 Px Restricted Anti-HIV-1 CD8+ T Cells Recognize Vestigial CTL Epitopes.
Kassanjee R, Pilcher CD, Busch MP, Murphy G, Facente SN, Keating SM, Mckinney E, Marson K, Price MA, Martin JN, Little SJ, Hecht FM, Kallas EG, Welte A, Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA)
Viral load criteria and threshold optimization to improve HIV incidence assay characteristics. AIDS. 2016 09 24; 30(15):2361-71.
Viral load criteria and threshold optimization to improve HIV incidence assay characteristics.
Pinzone MR, Graf E, Lynch L, McLaughlin B, Hecht FM, Connors M, Migueles SA, Hwang WT, Nunnari G, O'Doherty U
Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size. J Virol. 2016 Dec 01; 90(23):10436-10445.
Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size.
"I accuse" the Journal of unfair journalism. N Engl J Med. 1987 Mar 19; 316(12):754.
"I accuse" the Journal of unfair journalism.
Zaccaria A, Alimena G, Baccarani M, Billström R, Carbonell F, Castoldi GL, Fuscaldo K, Hecht F, Hossfeld DK, Mitelman F
Cytogenetic analyses in 89 patients with secondary hematologic disorders--results of a cooperative study. Cancer Genet Cytogenet. 1987 May; 26(1):65-74.
Cytogenetic analyses in 89 patients with secondary hematologic disorders--results of a cooperative study.
Kiniry BE, Ganesh A, Critchfield JW, Hunt PW, Hecht FM, Somsouk M, Deeks SG, Shacklett BL
Predominance of weakly cytotoxic, T-betLowEomesNeg CD8+ T-cells in human gastrointestinal mucosa: implications for HIV infection. Mucosal Immunol. 2017 07; 10(4):1008-1020.
Predominance of weakly cytotoxic, T-betLowEomesNeg CD8+ T-cells in human gastrointestinal mucosa: implications for HIV infection.
Adler E, Dhruva A, Moran PJ, Daubenmier J, Acree M, Epel ES, Bacchetti P, Prather AA, Mason A, Hecht FM
Impact of a Mindfulness-Based Weight-Loss Intervention on Sleep Quality Among Adults with Obesity: Data from the SHINE Randomized Controlled Trial. J Altern Complement Med. 2017 Mar; 23(3):188-195.
Impact of a Mindfulness-Based Weight-Loss Intervention on Sleep Quality Among Adults with Obesity: Data from the SHINE Randomized Controlled Trial.
Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren HG, Sönnerborg A, Lund O, Reyes-Terán G, Hecht FM, Deeks SG, Betts MR, Buggert M, Karlsson AC
Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017 01 13; 7:40354.
Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals.
Nititham J, Gupta R, Zeng X, Hartogensis W, Nixon DF, Deeks SG, Hecht FM, Liao W
Psoriasis risk SNPs and their association with HIV-1 control. Hum Immunol. 2017 Feb; 78(2):179-184.
Psoriasis risk SNPs and their association with HIV-1 control.
Palar K, Napoles T, Hufstedler LL, Seligman H, Hecht FM, Madsen K, Ryle M, Pitchford S, Frongillo EA, Weiser SD
Journal of urban health : bulletin of the New York Academy of Medicine
Comprehensive and Medically Appropriate Food Support Is Associated with Improved HIV and Diabetes Health. J Urban Health. 2017 02; 94(1):87-99.
Comprehensive and Medically Appropriate Food Support Is Associated with Improved HIV and Diabetes Health.
Henje Blom E, Tymofiyeva O, Chesney MA, Ho TC, Moran P, Connolly CG, Duncan LG, Baldini L, Weng HY, Acree M, Goldman V, Hecht FM, Yang TT
Feasibility and Preliminary Efficacy of a Novel RDoC-Based Treatment Program for Adolescent Depression: "Training for Awareness Resilience and Action" (TARA)-A Pilot Study. Front Psychiatry. 2016; 7:208.
Feasibility and Preliminary Efficacy of a Novel RDoC-Based Treatment Program for Adolescent Depression: "Training for Awareness Resilience and Action" (TARA)-A Pilot Study.
Saslow LR, Mason AE, Kim S, Goldman V, Ploutz-Snyder R, Bayandorian H, Daubenmier J, Hecht FM, Moskowitz JT
An Online Intervention Comparing a Very Low-Carbohydrate Ketogenic Diet and Lifestyle Recommendations Versus a Plate Method Diet in Overweight Individuals With Type 2 Diabetes: A Randomized Controlled Trial. J Med Internet Res. 2017 02 13; 19(2):e36.
An Online Intervention Comparing a Very Low-Carbohydrate Ketogenic Diet and Lifestyle Recommendations Versus a Plate Method Diet in Overweight Individuals With Type 2 Diabetes: A Randomized Controlled Trial.
Rutishauser RL, Hartogensis W, Deguit CD, Krone M, Hoh R, Hecht FM, Pilcher CD, Bacchetti P, Deeks SG, Hunt PW, McCune JM
Early and Delayed Antiretroviral Therapy Results in Comparable Reductions in CD8+ T Cell Exhaustion Marker Expression. AIDS Res Hum Retroviruses. 2017 07; 33(7):658-667.
Early and Delayed Antiretroviral Therapy Results in Comparable Reductions in CD8+ T Cell Exhaustion Marker Expression.
Charlins P, Schmitt K, Remling-Mulder L, Hogan LE, Hanhauser E, Hobbs KS, Hecht F, Deeks SG, Henrich TJ, Akkina R
A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads. Virology. 2017 07; 507:135-139.
A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads.
Khoury G, Fromentin R, Solomon A, Hartogensis W, Killian M, Hoh R, Somsouk M, Hunt PW, Girling V, Sinclair E, Bacchetti P, Anderson JL, Hecht FM, Deeks SG, Cameron PU, Chomont N, Lewin SR
Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy. J Infect Dis. 2017 03 15; 215(6):911-919.
Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.
Keating SM, Pilcher CD, Jain V, Lebedeva M, Hampton D, Abdel-Mohsen M, Deng X, Murphy G, Welte A, Facente SN, Hecht F, Deeks SG, Pillai SK, Busch MP
HIV Antibody Level as a Marker of HIV Persistence and Low-Level Viral Replication. J Infect Dis. 2017 07 01; 216(1):72-81.
HIV Antibody Level as a Marker of HIV Persistence and Low-Level Viral Replication.
Mason AE, Vainik U, Acree M, Tomiyama AJ, Dagher A, Epel ES, Hecht FM
Improving Assessment of the Spectrum of Reward-Related Eating: The RED-13. Front Psychol. 2017; 8:795.
Improving Assessment of the Spectrum of Reward-Related Eating: The RED-13.
Gurfein BT, Hasdemir B, Milush JM, Touma C, Palme R, Nixon DF, Darcel N, Hecht FM, Bhargava A
Enriched environment and stress exposure influence splenic B lymphocyte composition. PLoS One. 2017; 12(7):e0180771.
Enriched environment and stress exposure influence splenic B lymphocyte composition.
de Mulder M, SenGupta D, Deeks SG, Martin JN, Pilcher CD, Hecht FM, Sacha JB, Nixon DF, Michaud HA
Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers. Retrovirology. 2017 Aug 22; 14(1):41.
Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.
Hiener B, Horsburgh BA, Eden JS, Barton K, Schlub TE, Lee E, von Stockenstrom S, Odevall L, Milush JM, Liegler T, Sinclair E, Hoh R, Boritz EA, Douek D, Fromentin R, Chomont N, Deeks SG, Hecht FM, Palmer S
Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants. Cell Rep. 2017 Oct 17; 21(3):813-822.
Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants.
Batchelder AW, Carrico AW, Acree M, Hecht FM, Moskowitz JT
Positive and Negative Self-Conscious Emotion and Transmission Risk Following HIV Diagnosis. AIDS Behav. 2018 05; 22(5):1496-1502.
Positive and Negative Self-Conscious Emotion and Transmission Risk Following HIV Diagnosis.
Saslow LR, Daubenmier JJ, Moskowitz JT, Kim S, Murphy EJ, Phinney SD, Ploutz-Snyder R, Goldman V, Cox RM, Mason AE, Moran P, Hecht FM
Twelve-month outcomes of a randomized trial of a moderate-carbohydrate versus very low-carbohydrate diet in overweight adults with type 2 diabetes mellitus or prediabetes. Nutr Diabetes. 2017 12 21; 7(12):304.
Twelve-month outcomes of a randomized trial of a moderate-carbohydrate versus very low-carbohydrate diet in overweight adults with type 2 diabetes mellitus or prediabetes.
Translocations in T-cell leukemia and lymphoma. N Engl J Med. 1985 09 19; 313(12):758-9.
Translocations in T-cell leukemia and lymphoma.
Prenatal diagnosis: a broader perspective. JAMA. 1980 Jun 06; 243(21):2157.
Prenatal diagnosis: a broader perspective.
Caution about chorionic villi sampling in the first trimester. N Engl J Med. 1984 May 24; 310(21):1388.
Caution about chorionic villi sampling in the first trimester.
Immunoglobulin expression in Burkitt's lymphoma and leukemia. N Engl J Med. 1982 Dec 16; 307(25):1583.
Immunoglobulin expression in Burkitt's lymphoma and leukemia.
Antibiotics containing trimethoprim and the fragile X chromosome. N Engl J Med. 1983 Feb 03; 308(5):285-6.
Antibiotics containing trimethoprim and the fragile X chromosome.
Clewell WH, Johnson ML, Meier PR, Newkirk JB, Zide SL, Hendee RW, Bowes WA, Hecht F, O'Keeffe D, Henry GP, Shikes RH
A surgical approach to the treatment of fetal hydrocephalus. N Engl J Med. 1982 Jun 03; 306(22):1320-5.
A surgical approach to the treatment of fetal hydrocephalus.
The physician as a risk factor in midtrimester amniocentesis. N Engl J Med. 1982 Jun 24; 306(25):1553.
The physician as a risk factor in midtrimester amniocentesis.
Chromosome translocations in cancer. N Engl J Med. 1981 Jun 11; 304(24):1493.
Clewell WH, Johnson ML, Meier PR, Newkirk JB, Hendee RW, Bowes WA, Zide SL, Hecht F, Henry G, O'Keeffe D
Placement of ventriculo-amniotic shunt for hydrocephalus in a fetus. N Engl J Med. 1981 Oct 15; 305(16):955.
Placement of ventriculo-amniotic shunt for hydrocephalus in a fetus.
Position effect in 8;14 translocation in Burkitt's lymphoma. N Engl J Med. 1981 Jan 15; 304(3):174-5.
Position effect in 8;14 translocation in Burkitt's lymphoma.
Huang L, Hecht FM, Stansell JD, Montanti R, Hadley WK, Hopewell PC
American journal of respiratory and critical care medicine
Suspected Pneumocystis carinii pneumonia with a negative induced sputum examination. Is early bronchoscopy useful? Am J Respir Crit Care Med. 1995 Jun; 151(6):1866-71.
Suspected Pneumocystis carinii pneumonia with a negative induced sputum examination. Is early bronchoscopy useful?
Lebares CC, Coaston TN, Delucchi KL, Guvva EV, Shen WT, Staffaroni AM, Kramer JH, Epel ES, Hecht FM, Ascher NL, Harris HW, Cole SW
Enhanced Stress Resilience Training in Surgeons: Iterative Adaptation and Biopsychosocial Effects in 2 Small Randomized Trials. Ann Surg. 2021 03 01; 273(3):424-432.
Enhanced Stress Resilience Training in Surgeons: Iterative Adaptation and Biopsychosocial Effects in 2 Small Randomized Trials.
CD4+ T-lymphocyte measures in the treatment of individuals infected with human immunodeficiency virus type 1. A review for clinical practitioners. Arch Intern Med. 1994 Jul 25; 154(14):1561-73.
CD4+ T-lymphocyte measures in the treatment of individuals infected with human immunodeficiency virus type 1. A review for clinical practitioners.
Preventive health care for adults with HIV infection. JAMA. 1993 Mar 03; 269(9):1144-53.
Preventive health care for adults with HIV infection.
Murder of son with a genital malformation. Am J Med Genet. 1995 Sep 25; 58(4):381.
Murder of son with a genital malformation.
Saslow LR, Moskowitz JT, Mason AE, Daubenmier J, Liestenfeltz B, Missel AL, Bayandorian H, Aikens JE, Kim S, Hecht FM
Intervention Enhancement Strategies Among Adults With Type 2 Diabetes in a Very Low-Carbohydrate Web-Based Program: Evaluating the Impact With a Randomized Trial. JMIR Diabetes. 2020 Sep 09; 5(3):e15835.
Intervention Enhancement Strategies Among Adults With Type 2 Diabetes in a Very Low-Carbohydrate Web-Based Program: Evaluating the Impact With a Randomized Trial.
Schnittman SR, Deitchman AN, Beck-Engeser G, Ahn H, York VA, Hartig H, Hecht FM, Martin JN, Deeks SG, Aweeka FT, Hunt PW
Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus. J Infect Dis. 2021 05 20; 223(9):1621-1630.
Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus.
Bangsberg D, Tulsky JP, Hecht FM, Moss AR
Protease inhibitors in the homeless. JAMA. 1997 Jul 02; 278(1):63-5.
Hecht FM, Wheat J, Korzun AH, Hafner R, Skahan KJ, Larsen R, Limjoco MT, Simpson M, Schneider D, Keefer MC, Clark R, Lai KK, Jacobson JM, Squires K, Bartlett JA, Powderly W
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association
Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Oct 01; 16(2):100-7.
J Acquir Immune Defic Syndr Hum Retrovirol
Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial.
Kiniry BE, Hunt PW, Hecht FM, Somsouk M, Deeks SG, Shacklett BL
Differential Expression of CD8+ T Cell Cytotoxic Effector Molecules in Blood and Gastrointestinal Mucosa in HIV-1 Infection. J Immunol. 2018 03 01; 200(5):1876-1888.
Differential Expression of CD8+ T Cell Cytotoxic Effector Molecules in Blood and Gastrointestinal Mucosa in HIV-1 Infection.
Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP
New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998 Jul 01; 280(1):42-8.
New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.
Bindman AB, Osmond D, Hecht FM, Lehman JS, Vranizan K, Keane D, Reingold A
Multistate evaluation of anonymous HIV testing and access to medical care. Multistate Evaluation of Surveillance of HIV (MESH) Study Group. JAMA. 1998 Oct 28; 280(16):1416-20.
Multistate evaluation of anonymous HIV testing and access to medical care. Multistate Evaluation of Surveillance of HIV (MESH) Study Group.
Lurie P, Miller S, Hecht F, Chesney M, Lo B
Postexposure prophylaxis after nonoccupational HIV exposure: clinical, ethical, and policy considerations. JAMA. 1998 Nov 25; 280(20):1769-73.
Postexposure prophylaxis after nonoccupational HIV exposure: clinical, ethical, and policy considerations.
Hecht FM, Grant RM, Petropoulos CJ, Dillon B, Chesney MA, Tian H, Hellmann NS, Bandrapalli NI, Digilio L, Branson B, Kahn JO
Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med. 1998 Jul 30; 339(5):307-11.
Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.
H. influenzae vaccines in HIV. N Engl J Med. 1992 Jun 04; 326(23):1569; author reply 1570-1.
Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, Cohen PT, Grant RM
HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy. AIDS. 1999 Apr 16; 13(6):F35-43.
HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy.
Weng HY, Lewis-Peacock JA, Hecht FM, Uncapher MR, Ziegler DA, Farb NAS, Goldman V, Skinner S, Duncan LG, Chao MT, Gazzaley A
Focus on the Breath: Brain Decoding Reveals Internal States of Attention During Meditation. Front Hum Neurosci. 2020; 14:336.
Focus on the Breath: Brain Decoding Reveals Internal States of Attention During Meditation.
Hecht FM, Wilson IB, Wu AW, Cook RL, Turner BJ
Optimizing care for persons with HIV infection. Society of General Internal Medicine AIDS Task Force. Ann Intern Med. 1999 Jul 20; 131(2):136-43.
Optimizing care for persons with HIV infection. Society of General Internal Medicine AIDS Task Force.
Osmond DH, Bindman AB, Vranizan K, Lehman JS, Hecht FM, Keane D, Reingold A
Name-based surveillance and public health interventions for persons with HIV infection. Multistate Evaluation of Surveillance for HIV Study Group. Ann Intern Med. 1999 Nov 16; 131(10):775-9.
Name-based surveillance and public health interventions for persons with HIV infection. Multistate Evaluation of Surveillance for HIV Study Group.
Elbeik T, Charlebois E, Nassos P, Kahn J, Hecht FM, Yajko D, Ng V, Hadley K
Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5. J Clin Microbiol. 2000 Mar; 38(3):1113-20.
Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.
Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000 Mar 10; 14(4):357-66.
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.
Hecht FM, Chesney MA, Lehman JS, Osmond D, Vranizan K, Colman S, Keane D, Reingold A, Bindman AB
Does HIV reporting by name deter testing? MESH Study Group. AIDS. 2000 Aug 18; 14(12):1801-8.
Does HIV reporting by name deter testing? MESH Study Group.
Chesney MA, Ickovics J, Hecht FM, Sikipa G, Rabkin J
Adherence: a necessity for successful HIV combination therapy. AIDS. 1999; 13 Suppl A:S271-8.
Adherence: a necessity for successful HIV combination therapy.
Why does Pneumocystis carinii pneumonia still occur? AIDS. 2000 Nov 10; 14(16):2611-2.
Why does Pneumocystis carinii pneumonia still occur?
Schito AM, Vittinghoff E, Hecht FM, Elkins MK, Kahn JO, Levy JA, Oksenberg JR
Longitudinal analysis of T-cell receptor gene use by CD8(+) T cells in early human immunodeficiency virus infection in patients receiving highly active antiretroviral therapy. Blood. 2001 Jan 01; 97(1):214-20.
Longitudinal analysis of T-cell receptor gene use by CD8(+) T cells in early human immunodeficiency virus infection in patients receiving highly active antiretroviral therapy.
Stranford SA, Ong JC, Martinez-Marino B, Busch M, Hecht FM, Kahn J, Levy JA
Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection. Proc Natl Acad Sci U S A. 2001 Jan 16; 98(2):597-602.
Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.
Altfeld M, Rosenberg ES, Shankarappa R, Mukherjee JS, Hecht FM, Eldridge RL, Addo MM, Poon SH, Phillips MN, Robbins GK, Sax PE, Boswell S, Kahn JO, Brander C, Goulder PJ, Levy JA, Mullins JI, Walker BD
Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med. 2001 Jan 15; 193(2):169-80.
Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.
Improving on a coin toss to predict patient adherence to medications. Ann Intern Med. 2001 May 15; 134(10):1004-6.
Improving on a coin toss to predict patient adherence to medications.
A new focus on primary HIV infection. AIDS Clin Care. 1996 Sep; 8(9):72, 75.
Measuring HIV treatment adherence in clinical practice. AIDS Clin Care. 1998 Aug; 10(8):57-9.
Measuring HIV treatment adherence in clinical practice.
Antiretrovirals for HIV nephropathy? AIDS Clin Care. 1999 Jun; 11(6):50.
Day CL, Shea AK, Altfeld MA, Olson DP, Buchbinder SP, Hecht FM, Rosenberg ES, Walker BD, Kalams SA
Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles. J Virol. 2001 Jul; 75(14):6279-91.
Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles.
Mason AE, Hecht FM, Daubenmier JJ, Sbarra DA, Lin J, Moran PJ, Schleicher SG, Acree M, Prather AA, Epel ES
Weight Loss Maintenance and Cellular Aging in the Supporting Health Through Nutrition and Exercise Study. Psychosom Med. 2018 09; 80(7):609-619.
Weight Loss Maintenance and Cellular Aging in the Supporting Health Through Nutrition and Exercise Study.
Evaluating HIV-infected patients with headache: who needs computed tomography? Headache. 2001 May; 41(5):441-8.
Evaluating HIV-infected patients with headache: who needs computed tomography?
Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, Moss A
Journal of acquired immune deficiency syndromes (1999)
Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr. 2001 Apr 15; 26(5):435-42.
Provider assessment of adherence to HIV antiretroviral therapy.
Boswell SL, Hecht FM, Powderly WG, Soloway B, Volberding PA
HIV expertise: a roundtable. AIDS Clin Care. 2001 Sep; 13(9):79-81, 84-5.
Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO
Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS. 2002 May 24; 16(8):1119-29.
Use of laboratory tests and clinical symptoms for identification of primary HIV infection.
Gascon RL, Narváez AB, Zhang R, Kahn JO, Hecht FM, Herndier BG, McGrath MS
Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion. J Acquir Immune Defic Syndr. 2002 Jun 01; 30(2):146-53.
Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion.
Grant RM, Hecht FM, Warmerdam M, Liu L, Liegler T, Petropoulos CJ, Hellmann NS, Chesney M, Busch MP, Kahn JO
Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA. 2002 Jul 10; 288(2):181-8.
Time trends in primary HIV-1 drug resistance among recently infected persons.
Kellerman SE, Lehman JS, Lansky A, Stevens MR, Hecht FM, Bindman AB, Wortley PM
HIV testing within at-risk populations in the United States and the reasons for seeking or avoiding HIV testing. J Acquir Immune Defic Syndr. 2002 Oct 01; 31(2):202-10.
HIV testing within at-risk populations in the United States and the reasons for seeking or avoiding HIV testing.
Lansky A, Lehman JS, Gatwood J, Hecht FM, Fleming PL
Changes in HIV testing after implementation of name-based HIV case surveillance in New Mexico. Am J Public Health. 2002 Nov; 92(11):1757.
Changes in HIV testing after implementation of name-based HIV case surveillance in New Mexico.
Colfax GN, Lehman JS, Bindman AB, Vittinghoff E, Vranizan K, Fleming PL, Chesney M, Osmond D, Hecht FM, Multisite Evaluation of Surveillance of HIV (MESH) Study Group
What happened to home HIV test collection kits? Intent to use kits, actual use, and barriers to use among persons at risk for HIV infection. AIDS Care. 2002 Oct; 14(5):675-82.
What happened to home HIV test collection kits? Intent to use kits, actual use, and barriers to use among persons at risk for HIV infection.
Smith DE, Kaufmann GR, Kahn JO, Hecht FM, Grey PA, Zaunders JJ, Cunningham PH, Carr A, Duncombe C, Quan DC, Petersen A, Cooper DA
Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine, and nelfinavir before complete HIV type 1 seroconversion. AIDS Res Hum Retroviruses. 2003 Mar; 19(3):189-99.
Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine, and nelfinavir before complete HIV type 1 seroconversion.
Rawal BD, Degula A, Lebedeva L, Janssen RS, Hecht FM, Sheppard HW, Busch MP
Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. J Acquir Immune Defic Syndr. 2003 Jul 01; 33(3):349-55.
Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection.
Jacobson MA, Liu L, Khayam-Bashi H, Deeks SG, Hecht FM, Kahn J
Absolute or total lymphocyte count as a marker for the CD4 T lymphocyte criterion for initiating antiretroviral therapy. AIDS. 2003 Apr 11; 17(6):917-9.
Absolute or total lymphocyte count as a marker for the CD4 T lymphocyte criterion for initiating antiretroviral therapy.
Altfeld M, Addo MM, Rosenberg ES, Hecht FM, Lee PK, Vogel M, Yu XG, Draenert R, Johnston MN, Strick D, Allen TM, Feeney ME, Kahn JO, Sekaly RP, Levy JA, Rockstroh JK, Goulder PJ, Walker BD
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS. 2003 Dec 05; 17(18):2581-91.
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
Benhamou G, Opsahl S, Vinardi O, Hecht F, Vilotte J
Chirurgie; memoires de l'Academie de chirurgie
[Reevaluation of surgical treatment of cancers of the anus. Therapeutic proposals based on an experience with 33 patients]. Chirurgie. 1997; 122(5-6):343-5.
[Reevaluation of surgical treatment of cancers of the anus. Therapeutic proposals based on an experience with 33 patients].
Aandahl EM, Michaëlsson J, Moretto WJ, Hecht FM, Nixon DF
Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol. 2004 Mar; 78(5):2454-9.
Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens.
Martinez-Mariño B, Ashlock BM, Shiboski S, Hecht FM, Levy JA
Effect of IL-2 therapy on CD8+ cell noncytotoxic anti-HIV response during primary HIV-1 infection. J Clin Immunol. 2004 Mar; 24(2):135-44.
Effect of IL-2 therapy on CD8+ cell noncytotoxic anti-HIV response during primary HIV-1 infection.
Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB, Hunt P, Martin JN, Kahn JO, Levy J, McGrath MS, Hecht FM
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood. 2004 Aug 15; 104(4):942-7.
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.
Barbour JD, Hecht FM, Wrin T, Segal MR, Ramstead CA, Liegler TJ, Busch MP, Petropoulos CJ, Hellmann NS, Kahn JO, Grant RM
Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection. J Infect Dis. 2004 Jul 15; 190(2):251-6.
Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection.
Aandahl EM, Quigley MF, Moretto WJ, Moll M, Gonzalez VD, Sönnerborg A, Lindbäck S, Hecht FM, Deeks SG, Rosenberg MG, Nixon DF, Sandberg JK
Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment. Blood. 2004 Dec 01; 104(12):3672-8.
Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment.
The decline of NIH's peer-review system? N Engl J Med. 1979 Nov 08; 301(19):1068.
The decline of NIH's peer-review system?
Barbour JD, Hecht FM, Wrin T, Liegler TJ, Ramstead CA, Busch MP, Segal MR, Petropoulos CJ, Grant RM
Persistence of primary drug resistance among recently HIV-1 infected adults. AIDS. 2004 Aug 20; 18(12):1683-9.
Persistence of primary drug resistance among recently HIV-1 infected adults.
Hecht FM, Moskowitz JT, Moran P, Epel ES, Bacchetti P, Acree M, Kemeny ME, Mendes WB, Duncan LG, Weng H, Levy JA, Deeks SG, Folkman S
A randomized, controlled trial of mindfulness-based stress reduction in HIV infection. Brain Behav Immun. 2018 10; 73:331-339.
A randomized, controlled trial of mindfulness-based stress reduction in HIV infection.
Elkins MK, Vittinghoff E, Baranzini SE, Hecht FM, Sriram U, Busch MP, Levy JA, Oksenberg JR, San Francisco Primary Infection Group
Longitudinal analysis of B cell repertoire and antibody gene rearrangements during early HIV infection. Genes Immun. 2005 Feb; 6(1):66-9.
Longitudinal analysis of B cell repertoire and antibody gene rearrangements during early HIV infection.
Martinez-Mariño B, Shiboski S, Hecht FM, Kahn JO, Levy JA
Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAART. AIDS. 2004 Oct 21; 18(15):1991-9.
Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAART.
Bias control in trials of bodywork: a review of methodological issues. J Altern Complement Med. 2005 Apr; 11(2):333-42.
Bias control in trials of bodywork: a review of methodological issues.
Jones MS, Kapoor A, Lukashov VV, Simmonds P, Hecht F, Delwart E
New DNA viruses identified in patients with acute viral infection syndrome. J Virol. 2005 Jul; 79(13):8230-6.
New DNA viruses identified in patients with acute viral infection syndrome.
Nucleic acid amplification testing for diagnosis of acute HIV infection: has the time come? AIDS. 2005 Aug 12; 19(12):1317-9.
Nucleic acid amplification testing for diagnosis of acute HIV infection: has the time come?
Mehling WE, Hamel KA, Acree M, Byl N, Hecht FM
Alternative therapies in health and medicine
Randomized, controlled trial of breath therapy for patients with chronic low-back pain. Altern Ther Health Med. 2005 Jul-Aug; 11(4):44-52.
Randomized, controlled trial of breath therapy for patients with chronic low-back pain.
Lennette ET, Busch MP, Hecht FM, Levy JA
Potential herpesvirus interaction during HIV type 1 primary infection. AIDS Res Hum Retroviruses. 2005 Oct; 21(10):869-75.
Potential herpesvirus interaction during HIV type 1 primary infection.
Roland ME, Neilands TB, Krone MR, Katz MH, Franses K, Grant RM, Busch MP, Hecht FM, Shacklett BL, Kahn JO, Bamberger JD, Coates TJ, Chesney MA, Martin JN
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Seroconversion following nonoccupational postexposure prophylaxis against HIV. Clin Infect Dis. 2005 Nov 15; 41(10):1507-13.
Seroconversion following nonoccupational postexposure prophylaxis against HIV.
Moll M, Snyder-Cappione J, Spotts G, Hecht FM, Sandberg JK, Nixon DF
Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2. Blood. 2006 Apr 15; 107(8):3081-3.
Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2.
Resistance testing in drug-naive HIV-infected patients: is it time? Clin Infect Dis. 2005 Nov 01; 41(9):1324-5.
Resistance testing in drug-naive HIV-infected patients: is it time?
Hare CB, Pappalardo BL, Busch MP, Karlsson AC, Phelps BH, Alexander SS, Bentsen C, Ramstead CA, Nixon DF, Levy JA, Hecht FM
Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection. Clin Infect Dis. 2006 Mar 01; 42(5):700-8.
Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.
Newly diagnosed HIV infection. N Engl J Med. 2006 Feb 16; 354(7):771-2; author reply 771-2.
Deeks SG, Schweighardt B, Wrin T, Galovich J, Hoh R, Sinclair E, Hunt P, McCune JM, Martin JN, Petropoulos CJ, Hecht FM
Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses. J Virol. 2006 Jun; 80(12):6155-64.
Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses.
Killian MS, Fujimura SH, Hecht FM, Levy JA
Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment. AIDS. 2006 Jun 12; 20(9):1247-52.
Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment.
Killian MS, Norris PJ, Rawal BD, Lebedeva M, Hecht FM, Levy JA, Busch MP
The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response. AIDS Res Hum Retroviruses. 2006 Jul; 22(7):640-7.
The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response.
A piece of my mind. The CBC. JAMA. 2006 Jul 12; 296(2):149-50.
Hecht FM, Wang L, Collier A, Little S, Markowitz M, Margolick J, Kilby JM, Daar E, Conway B, Holte S, AIEDRP Network
A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis. 2006 Sep 15; 194(6):725-33.
A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
Norris PJ, Pappalardo BL, Custer B, Spotts G, Hecht FM, Busch MP
Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res Hum Retroviruses. 2006 Aug; 22(8):757-62.
Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection.
Zimmerman ES, Sherman MP, Blackett JL, Neidleman JA, Kreis C, Mundt P, Williams SA, Warmerdam M, Kahn J, Hecht FM, Grant RM, de Noronha CM, Weyrich AS, Greene WC, Planelles V
Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo. J Virol. 2006 Nov; 80(21):10407-18.
Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.
Barbour JD, Hecht FM, Little SJ, Markowitz M, Daar ES, Kelleher AD, Routy JP, Campbell TB, Rosenberg ES, Segal MR, Weidler J, Grant RM
Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacity. AIDS. 2006 Oct 24; 20(16):2123-5.
Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacity.
Barfod TS, Hecht FM, Rubow C, Gerstoft J
Physicians' communication with patients about adherence to HIV medication in San Francisco and Copenhagen: a qualitative study using Grounded Theory. BMC Health Serv Res. 2006 Dec 04; 6:154.
Physicians' communication with patients about adherence to HIV medication in San Francisco and Copenhagen: a qualitative study using Grounded Theory.
Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC
Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006 Dec; 12(12):1365-71.
Microbial translocation is a cause of systemic immune activation in chronic HIV infection.
Colfax GN, Vittinghoff E, Grant R, Lum P, Spotts G, Hecht FM
Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance. AIDS. 2007 Jan 11; 21(2):239-41.
Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance.
Karlsson AC, Iversen AK, Chapman JM, de Oliviera T, Spotts G, McMichael AJ, Davenport MP, Hecht FM, Nixon DF
Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape. PLoS One. 2007 Feb 21; 2(2):e225.
Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.
Northfield JW, Loo CP, Barbour JD, Spotts G, Hecht FM, Klenerman P, Nixon DF, Michaëlsson J
Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point. J Virol. 2007 Jun; 81(11):5759-65.
Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point.
The relation between symptoms, viral load, and viral load set point in primary HIV infection. J Acquir Immune Defic Syndr. 2007 Aug 01; 45(4):445-8.
The relation between symptoms, viral load, and viral load set point in primary HIV infection.
Lessons from primary HIV infection. Focus. 2007 Feb; 22(2):1-5.
Mehling WE, Jacobs B, Acree M, Wilson L, Bostrom A, West J, Acquah J, Burns B, Chapman J, Hecht FM
Symptom management with massage and acupuncture in postoperative cancer patients: a randomized controlled trial. J Pain Symptom Manage. 2007 Mar; 33(3):258-66.
Symptom management with massage and acupuncture in postoperative cancer patients: a randomized controlled trial.
Lessons from an HIV transmission pair. J Infect Dis. 2007 May 01; 195(9):1239-41.
Barbour JD, Sriram U, Caillier SJ, Levy JA, Hecht FM, Oksenberg JR
Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression. PLoS Pathog. 2007 Apr; 3(4):e43.
Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression.
Fryer JF, Delwart E, Hecht FM, Bernardin F, Jones MS, Shah N, Baylis SA
Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion. 2007 Jun; 47(6):1054-61.
Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals.
Sriram U, Wong M, Caillier SJ, Hecht FM, Elkins MK, Levy JA, Oksenberg JR, Baranzini SE
Quantitative longitudinal analysis of T cell receptor repertoire expression in HIV-infected patients on antiretroviral and interleukin-2 therapy. AIDS Res Hum Retroviruses. 2007 May; 23(5):741-7.
Quantitative longitudinal analysis of T cell receptor repertoire expression in HIV-infected patients on antiretroviral and interleukin-2 therapy.
Karlsson AC, Chapman JM, Heiken BD, Hoh R, Kallas EG, Martin JN, Hecht FM, Deeks SG, Nixon DF
Antiretroviral drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from Gag to Pol. J Virol. 2007 Oct; 81(20):11543-8.
Antiretroviral drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from Gag to Pol.
Owen RE, Sinclair E, Emu B, Heitman JW, Hirschkorn DF, Epling CL, Tan QX, Custer B, Harris JM, Jacobson MA, McCune JM, Martin JN, Hecht FM, Deeks SG, Norris PJ
Loss of T cell responses following long-term cryopreservation. J Immunol Methods. 2007 Sep 30; 326(1-2):93-115.
Loss of T cell responses following long-term cryopreservation.
Dolan MJ, Kulkarni H, Camargo JF, He W, Smith A, Anaya JM, Miura T, Hecht FM, Mamtani M, Pereyra F, Marconi V, Mangano A, Sen L, Bologna R, Clark RA, Anderson SA, Delmar J, O'Connell RJ, Lloyd A, Martin J, Ahuja SS, Agan BK, Walker BD, Deeks SG, Ahuja SK
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol. 2007 Dec; 8(12):1324-36.
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.
Ndhlovu LC, Loo CP, Spotts G, Nixon DF, Hecht FM
FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection. J Leukoc Biol. 2008 Feb; 83(2):254-62.
FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection.
Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, Chapman JM, Erickson AL, Agrawal A, Spotts G, Hecht FM, Rakoff-Nahoum S, Lenz J, Ostrowski MA, Nixon DF
T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog. 2007 Nov; 3(11):e165.
T cell responses to human endogenous retroviruses in HIV-1 infection.
Long BR, Michaelsson J, Loo CP, Ballan WM, Vu BA, Hecht FM, Lanier LL, Chapman JM, Nixon DF
Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus. Clin Vaccine Immunol. 2008 Jan; 15(1):120-30.
Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus.
Michaëlsson J, Long BR, Loo CP, Lanier LL, Spotts G, Hecht FM, Nixon DF
Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2. J Infect Dis. 2008 Jan 01; 197(1):117-25.
Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.
Long BR, Ndhlovu LC, Oksenberg JR, Lanier LL, Hecht FM, Nixon DF, Barbour JD
Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection. J Virol. 2008 May; 82(10):4785-92.
Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.
Liu L, May S, Richman DD, Hecht FM, Markowitz M, Daar ES, Routy JP, Margolick JB, Collier AC, Woelk CH, Little SJ, Smith DM
Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance. AIDS. 2008 Apr 23; 22(7):835-9.
Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance.
Louie B, Wong E, Klausner JD, Liska S, Hecht F, Dowling T, Obeso M, Phillips SS, Pandori MW
Assessment of rapid tests for detection of human immunodeficiency virus-specific antibodies in recently infected individuals. J Clin Microbiol. 2008 Apr; 46(4):1494-7.
Assessment of rapid tests for detection of human immunodeficiency virus-specific antibodies in recently infected individuals.
Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, He W, O'Connell RJ, Marconi VC, Delmar J, Eron J, Clark RA, Frost S, Martin J, Ahuja SS, Deeks SG, Little S, Richman D, Hecht FM, Dolan MJ
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals. Nat Med. 2008 Apr; 14(4):413-20.
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals.
Carrico AW, Johnson MO, Morin SF, Remien RH, Riley ED, Hecht FM, Fuchs D
Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy. Brain Behav Immun. 2008 Nov; 22(8):1257-62.
Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy.
Owotade FJ, Shiboski CH, Poole L, Ramstead CA, Malvin K, Hecht FM, Greenspan JS
Prevalence of oral disease among adults with primary HIV infection. Oral Dis. 2008 Sep; 14(6):497-9.
Prevalence of oral disease among adults with primary HIV infection.
Willberg CB, McConnell JJ, Eriksson EM, Bragg LA, York VA, Liegler TJ, Hecht FM, Grant RM, Nixon DF
Immunity to HIV-1 is influenced by continued natural exposure to exogenous virus. PLoS Pathog. 2008 Oct; 4(10):e1000185.
Immunity to HIV-1 is influenced by continued natural exposure to exogenous virus.
Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha AR, Long BR, Wong JC, Satkunarajah M, Schweneker M, Chapman JM, Gyenes G, Vali B, Hyrcza MD, Yue FY, Kovacs C, Sassi A, Loutfy M, Halpenny R, Persad D, Spotts G, Hecht FM, Chun TW, McCune JM, Kaul R, Rini JM, Nixon DF, Ostrowski MA
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med. 2008 Nov 24; 205(12):2763-79.
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection.
Killian MS, Roop J, Ng S, Hecht FM, Levy JA
CD8+ cell anti-HIV activity rapidly increases upon discontinuation of early antiretroviral therapy. J Clin Immunol. 2009 May; 29(3):311-8.
CD8+ cell anti-HIV activity rapidly increases upon discontinuation of early antiretroviral therapy.
Kelley CF, Kitchen CM, Hunt PW, Rodriguez B, Hecht FM, Kitahata M, Crane HM, Willig J, Mugavero M, Saag M, Martin JN, Deeks SG
Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis. 2009 Mar 15; 48(6):787-94.
Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.
Apuzzo LG, Vaida F, Gallant JE, Ernstrom KB, Little SJ, Routy JP, Collier AC, Conway B, Markowitz MH, Hecht FM, Walker BD, Connick E, Margolick JB
Tolerability and efficacy of PI versus NNRTI-based regimens in subjects receiving HAART during acute or early HIV infection. J Acquir Immune Defic Syndr. 2009 Mar 01; 50(3):267-75.
Tolerability and efficacy of PI versus NNRTI-based regimens in subjects receiving HAART during acute or early HIV infection.
Barbour JD, Ndhlovu LC, Xuan Tan Q, Ho T, Epling L, Bredt BM, Levy JA, Hecht FM, Sinclair E
High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replication. PLoS One. 2009; 4(2):e4408.
High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replication.
Morgan R, Hecht F, Cleary ML, Sklar J, Link MP
Leukemia with Down's syndrome: translocation between chromosomes 1 and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome. Blood. 1985 Dec; 66(6):1466-8.
Leukemia with Down's syndrome: translocation between chromosomes 1 and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome.
Clinical presentation and diagnosis of primary HIV-1 infection. Curr Opin HIV AIDS. 2008 Jan; 3(1):10-5.
Clinical presentation and diagnosis of primary HIV-1 infection.
Mehling WE, Gopisetty V, Daubenmier J, Price CJ, Hecht FM, Stewart A
Body awareness: construct and self-report measures. PLoS One. 2009; 4(5):e5614.
Body awareness: construct and self-report measures.
Streeck H, Jolin JS, Qi Y, Yassine-Diab B, Johnson RC, Kwon DS, Addo MM, Brumme C, Routy JP, Little S, Jessen HK, Kelleher AD, Hecht FM, Sekaly RP, Rosenberg ES, Walker BD, Carrington M, Altfeld M
Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol. 2009 Aug; 83(15):7641-8.
Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells.
Loo CP, Long BR, Hecht FM, Nixon DF, Michaëlsson J
HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens. AIDS Res Hum Retroviruses. 2009 Jun; 25(6):603-5.
HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens.
Snyder-Cappione JE, Loo CP, Carvalho KI, Kuylenstierna C, Deeks SG, Hecht FM, Rosenberg MG, Sandberg JK, Kallas EG, Nixon DF
Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression. AIDS. 2009 Sep 24; 23(15):1965-70.
Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression.
Garrison KE, Champiat S, York VA, Agrawal AT, Kallas EG, Martin JN, Hecht FM, Deeks SG, Nixon DF
Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses. Clin Vaccine Immunol. 2009 Sep; 16(9):1369-71.
Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses.
Huang W, Toma J, Stawiski E, Fransen S, Wrin T, Parkin N, Whitcomb JM, Coakley E, Hecht FM, Deeks SG, Gandhi RT, Eshleman SH, Petropoulos CJ
Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals. AIDS Res Hum Retroviruses. 2009 Aug; 25(8):795-802.
Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals.
Khurana S, Norris PJ, Busch MP, Haynes BF, Park S, Sasono P, Mlisana K, Salim AK, Hecht FM, Mulenga J, Chomba E, Hunter E, Allen S, Nemo G, Rodriguez-Chavez IR, Women's Interagency HIV Study Collaborative Study Group, Margolick JB, Multicenter AIDS Cohort Study (MACS), Golding H
HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection. J Clin Microbiol. 2010 Jan; 48(1):281-5.
HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.
Schweighardt B, Wrin T, Meiklejohn DA, Spotts G, Petropoulos CJ, Nixon DF, Hecht FM
Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruption. J Acquir Immune Defic Syndr. 2010 Jan; 53(1):36-46.
Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruption.
Naeger DM, Martin JN, Sinclair E, Hunt PW, Bangsberg DR, Hecht F, Hsue P, McCune JM, Deeks SG
Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease. PLoS One. 2010 Jan 29; 5(1):e8886.
Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease.
Hecht FM, Hartogensis W, Bragg L, Bacchetti P, Atchison R, Grant R, Barbour J, Deeks SG
HIV RNA level in early infection is predicted by viral load in the transmission source. AIDS. 2010 Apr 24; 24(7):941-5.
HIV RNA level in early infection is predicted by viral load in the transmission source.
Markowitz M, Vaida F, Hare CB, Boden D, Mohri H, Hecht FM, Kalayjian RC, Conrad A, Mildvan D, Aberg J, Hogan C, Kilby JM, Balfour HH, Schafer K, Richman D, Little S
The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection. J Infect Dis. 2010 May 01; 201(9):1298-302.
The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection.
Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes. PLoS One. 2010 04 21; 5(4):e10249.
Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes.
Favre D, Mold J, Hunt PW, Kanwar B, Loke P, Seu L, Barbour JD, Lowe MM, Jayawardene A, Aweeka F, Huang Y, Douek DC, Brenchley JM, Martin JN, Hecht FM, Deeks SG, McCune JM
Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med. 2010 May 19; 2(32):32ra36.
Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.
Ndhlovu LC, Sinclair E, Epling L, Tan QX, Ho T, Jha AR, Eccles-James I, Tincati C, Levy JA, Nixon DF, Hecht FM, Barbour JD
IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery. J Clin Immunol. 2010 Sep; 30(5):681-92.
IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery.
Ho JE, Deeks SG, Hecht FM, Xie Y, Schnell A, Martin JN, Ganz P, Hsue PY
Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals. AIDS. 2010 Jul 31; 24(12):1897-905.
Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals.
D'Souza MP, Axten KL, Hecht FM, Altfeld M
Acute HIV-1 infection: what's new? Where are we going? J Infect Dis. 2010 Oct 15; 202 Suppl 2:S267-9.
Acute HIV-1 infection: what's new? Where are we going?
The detection of acute HIV infection. J Infect Dis. 2010 Oct 15; 202 Suppl 2:S270-7.
International HIV Controllers Study, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N, Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H, Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE, Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch C, Bodner SJ, Bolan RK, Boudreaux ET, Bradley M, Braun JF, Brndjar JE, Brown SJ, Brown K, Brown ST, Burack J, Bush LM, Cafaro V, Campbell O, Campbell J, Carlson RH, Carmichael JK, Casey KK, Cavacuiti C, Celestin G, Chambers ST, Chez N, Chirch LM, Cimoch PJ, Cohen D, Cohn LE, Conway B, Cooper DA, Cornelson B, Cox DT, Cristofano MV, Cuchural G, Czartoski JL, Dahman JM, Daly JS, Davis BT, Davis K, Davod SM, DeJesus E, Dietz CA, Dunham E, Dunn ME, Ellerin TB, Eron JJ, Fangman JJ, Farel CE, Ferlazzo H, Fidler S, Fleenor-Ford A, Frankel R, Freedberg KA, French NK, Fuchs JD, Fuller JD, Gaberman J, Gallant JE, Gandhi RT, Garcia E, Garmon D, Gathe JC, Gaultier CR, Gebre W, Gilman FD, Gilson I, Goepfert PA, Gottlieb MS, Goulston C, Groger RK, Gurley TD, Haber S, Hardwicke R, Hardy WD, Harrigan PR, Hawkins TN, Heath S, Hecht FM, Henry WK, Hladek M, Hoffman RP, Horton JM, Hsu RK, Huhn GD, Hunt P, Hupert MJ, Illeman ML, Jaeger H, Jellinger RM, John M, Johnson JA, Johnson KL, Johnson H, Johnson K, Joly J, Jordan WC, Kauffman CA, Khanlou H, Killian RK, Kim AY, Kim DD, Kinder CA, Kirchner JT, Kogelman L, Kojic EM, Korthuis PT, Kurisu W, Kwon DS, LaMar M, Lampiris H, Lanzafame M, Lederman MM, Lee DM, Lee JM, Lee MJ, Lee ET, Lemoine J, Levy JA, Llibre JM, Liguori MA, Little SJ, Liu AY, Lopez AJ, Loutfy MR, Loy D, Mohammed DY, Man A, Mansour MK, Marconi VC, Markowitz M, Marques R, Martin JN, Martin HL, Mayer KH, McElrath MJ, McGhee TA, McGovern BH, McGowan K, McIntyre D, Mcleod GX, Menezes P, Mesa G, Metroka CE, Meyer-Olson D, Miller AO, Montgomery K, Mounzer KC, Nagami EH, Nagin I, Nahass RG, Nelson MO, Nielsen C, Norene DL, O'Connor DH, Ojikutu BO, Okulicz J, Oladehin OO, Oldfield EC, Olender SA, Ostrowski M, Owen WF, Pae E, Parsonnet J, Pavlatos AM, Perlmutter AM, Pierce MN, Pincus JM, Pisani L, Price LJ, Proia L, Prokesch RC, Pujet HC, Ramgopal M, Rathod A, Rausch M, Ravishankar J, Rhame FS, Richards CS, Richman DD, Rodes B, Rodriguez M, Rose RC, Rosenberg ES, Rosenthal D, Ross PE, Rubin DS, Rumbaugh E, Saenz L, Salvaggio MR, Sanchez WC, Sanjana VM, Santiago S, Schmidt W, Schuitemaker H, Sestak PM, Shalit P, Shay W, Shirvani VN, Silebi VI, Sizemore JM, Skolnik PR, Sokol-Anderson M, Sosman JM, Stabile P, Stapleton JT, Starrett S, Stein F, Stellbrink HJ, Sterman FL, Stone VE, Stone DR, Tambussi G, Taplitz RA, Tedaldi EM, Telenti A, Theisen W, Torres R, Tosiello L, Tremblay C, Tribble MA, Trinh PD, Tsao A, Ueda P, Vaccaro A, Valadas E, Vanig TJ, Vecino I, Vega VM, Veikley W, Wade BH, Walworth C, Wanidworanun C, Ward DJ, Warner DA, Weber RD, Webster D, Weis S, Wheeler DA, White DJ, Wilkins E, Winston A, Wlodaver CG, van't Wout A, Wright DP, Yang OO, Yurdin DL, Zabukovic BW, Zachary KC, Zeeman B, Zhao M
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010 Dec 10; 330(6010):1551-7.
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
Gourraud PA, Karaouni A, Woo JM, Schmidt T, Oksenberg JR, Hecht FM, Liegler TJ, Barbour JD
APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus-1 infection. Hum Immunol. 2011 Mar; 72(3):207-12.
APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus-1 infection.
Kuylenstierna C, Snyder-Cappione JE, Loo CP, Long BR, Gonzalez VD, Michaëlsson J, Moll M, Spotts G, Hecht FM, Nixon DF, Sandberg JK
NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infection. Scand J Immunol. 2011 Feb; 73(2):141-6.
NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infection.
Favre D, Stoddart CA, Emu B, Hoh R, Martin JN, Hecht FM, Deeks SG, McCune JM
HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells. Blood. 2011 Feb 17; 117(7):2189-99.
HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells.
Mehling WE, Gopisetty V, Acree M, Pressman A, Carey T, Goldberg H, Hecht FM, Avins AL
Acute low back pain and primary care: how to define recovery and chronification? Spine (Phila Pa 1976). 2011 Dec 15; 36(26):2316-23.
Acute low back pain and primary care: how to define recovery and chronification?
Jain V, Liegler T, Vittinghoff E, Hartogensis W, Bacchetti P, Poole L, Loeb L, Pilcher CD, Grant RM, Deeks SG, Hecht FM
Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009. PLoS One. 2010 Dec 10; 5(12):e15510.
Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009.
Jain V, Sucupira MC, Bacchetti P, Hartogensis W, Diaz RS, Kallas EG, Janini LM, Liegler T, Pilcher CD, Grant RM, Cortes R, Deeks SG, Hecht FM
Differential persistence of transmitted HIV-1 drug resistance mutation classes. J Infect Dis. 2011 Apr 15; 203(8):1174-81.
Differential persistence of transmitted HIV-1 drug resistance mutation classes.
SenGupta D, Tandon R, Vieira RG, Ndhlovu LC, Lown-Hecht R, Ormsby CE, Loh L, Jones RB, Garrison KE, Martin JN, York VA, Spotts G, Reyes-Terán G, Ostrowski MA, Hecht FM, Deeks SG, Nixon DF
Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection. J Virol. 2011 Jul; 85(14):6977-85.
Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.
Radvany RM, Schubert MS, Kiamar M, Jarzabek V, Koehler-Carone K, Kuban D, Hecht F
Lymphocyte subpopulation profiles and mitogen kinetics in immunological deficiency testing. J Clin Immunol. 1987 Jul; 7(4):312-8.
Lymphocyte subpopulation profiles and mitogen kinetics in immunological deficiency testing.
Smith SD, Morgan R, Gemmell R, Amylon MD, Link MP, Linker C, Hecht BK, Warnke R, Glader BE, Hecht F
Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34. Blood. 1988 Feb; 71(2):395-402.
Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34.
Hecht FM, Wellman R, Busch MP, Pilcher CD, Norris PJ, Margolick JB, Collier AC, Little SJ, Markowitz M, Routy JP, Holte S, Acute Infection Early Disease Research Program
Identifying the early post-HIV antibody seroconversion period. J Infect Dis. 2011 Aug 15; 204(4):526-33.
Identifying the early post-HIV antibody seroconversion period.
S Crane R, Hecht FM, Brewer J, Griffith GM, Hartogensis W, Koerbel L, Moran P, Sansom S, Yiangou A, Kuyken W
Can We Agree What Skilled Mindfulness-Based Teaching Looks Like? Lessons From Studying the MBI:TAC. Glob Adv Health Med. 2020; 9:2164956120964733.
Can We Agree What Skilled Mindfulness-Based Teaching Looks Like? Lessons From Studying the MBI:TAC.
Ho EY, Pak S, Leung G, Xu S, Yu CK, Hecht FM, Jih J, Chao MT
Pilot Cluster Randomized Controlled Trial of Integrative Nutritional Counseling Versus Standard Diabetes Self-Management Education for Chinese Americans with Type 2 Diabetes. Health Equity. 2020; 4(1):410-420.
Pilot Cluster Randomized Controlled Trial of Integrative Nutritional Counseling Versus Standard Diabetes Self-Management Education for Chinese Americans with Type 2 Diabetes.
Duncan LG, Moskowitz JT, Neilands TB, Dilworth SE, Hecht FM, Johnson MO
Mindfulness-based stress reduction for HIV treatment side effects: a randomized, wait-list controlled trial. J Pain Symptom Manage. 2012 Feb; 43(2):161-71.
Mindfulness-based stress reduction for HIV treatment side effects: a randomized, wait-list controlled trial.
Crawford TQ, Ndhlovu LC, Tan A, Carvidi A, Hecht FM, Sinclair E, Barbour JD
HIV-1 infection abrogates CD8+ T cell mitogen-activated protein kinase signaling responses. J Virol. 2011 Dec; 85(23):12343-50.
HIV-1 infection abrogates CD8+ T cell mitogen-activated protein kinase signaling responses.
Daubenmier J, Chao MT, Hartogensis W, Liu R, Moran PJ, Acree MC, Kristeller J, Epel ES, Hecht FM
Exploratory Analysis of Racial/Ethnic and Educational Differences in a Randomized Controlled Trial of a Mindfulness-Based Weight Loss Intervention. Psychosom Med. 2021 Jul-Aug 01; 83(6):503-514.
Exploratory Analysis of Racial/Ethnic and Educational Differences in a Randomized Controlled Trial of a Mindfulness-Based Weight Loss Intervention.
Rutishauser RL, Deguit CDT, Hiatt J, Blaeschke F, Roth TL, Wang L, Raymond KA, Starke CE, Mudd JC, Chen W, Smullin C, Matus-Nicodemos R, Hoh R, Krone M, Hecht FM, Pilcher CD, Martin JN, Koup RA, Douek DC, Brenchley JM, Sékaly RP, Pillai SK, Marson A, Deeks SG, McCune JM, Hunt PW
TCF-1 regulates HIV-specific CD8+ T cell expansion capacity. JCI Insight. 2021 02 08; 6(3).
TCF-1 regulates HIV-specific CD8+ T cell expansion capacity.
Weng HY, Ikeda MP, Lewis-Peacock JA, Chao MT, Fullwiley D, Goldman V, Skinner S, Duncan LG, Gazzaley A, Hecht FM
Toward a Compassionate Intersectional Neuroscience: Increasing Diversity and Equity in Contemplative Neuroscience. Front Psychol. 2020; 11:573134.
Toward a Compassionate Intersectional Neuroscience: Increasing Diversity and Equity in Contemplative Neuroscience.
Smarr BL, Aschbacher K, Fisher SM, Chowdhary A, Dilchert S, Puldon K, Rao A, Hecht FM, Mason AE
Feasibility of continuous fever monitoring using wearable devices. Sci Rep. 2020 12 14; 10(1):21640.
Feasibility of continuous fever monitoring using wearable devices.
Dhruva A, Wu C, Miaskowski C, Hartogensis W, Rugo HS, Adler SR, Kaptchuk TJ, Kelkar R, Agarawal S, Vadodaria A, Garris E, Hecht FM
A 4-Month Whole-Systems Ayurvedic Medicine Nutrition and Lifestyle Intervention Is Feasible and Acceptable for Breast Cancer Survivors: Results of a Single-Arm Pilot Clinical Trial. Glob Adv Health Med. 2020; 9:2164956120964712.
A 4-Month Whole-Systems Ayurvedic Medicine Nutrition and Lifestyle Intervention Is Feasible and Acceptable for Breast Cancer Survivors: Results of a Single-Arm Pilot Clinical Trial.
Rivas ML, Conneally PM, Hecht F, Lovrien EW, Magenis E, Merritt AD, Meyers DA, Palmer CG, Wang L
Linkage relationships of 1qh to Amy, Fy, PGM1, and Rh. Birth Defects Orig Artic Ser. 1975; 11(3):239-47.
Linkage relationships of 1qh to Amy, Fy, PGM1, and Rh.
Linkage relationships of 1qh to Amy, Fy, PGM1, and Rh. Cytogenet Cell Genet. 1975; 14(3-6):409-17.
Meyers DA, Conneally PM, Hecht F, Lovrien EW, Magenis E, Merritt AD, Palmer CG, Rivas ML, Wang L
Linkage group I: multipoint mapping. Birth Defects Orig Artic Ser. 1975; 11(3):211-9.
Meyers DA, Conneally PM, Hecht F, Lovrien EW, Magenis E, Merritt AD, Palmer GC, Rivas ML, Wang L
Linkage group I: multipoint mapping. Cytogenet Cell Genet. 1975; 14(3-6):381-9.
Bacchus-Souffan C, Fitch M, Symons J, Abdel-Mohsen M, Reeves DB, Hoh R, Stone M, Hiatt J, Kim P, Chopra A, Ahn H, York VA, Cameron DL, Hecht FM, Martin JN, Yukl SA, Mallal S, Cameron PU, Deeks SG, Schiffer JT, Lewin SR, Hellerstein MK, McCune JM, Hunt PW
Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART. PLoS Pathog. 2021 01; 17(1):e1009214.
Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART.
Feasibility Clinical Trial of Integrated Mind-Body Therapy for Chronic Low Back Pain
Corrigendum: Toward a Compassionate Intersectional Neuroscience: Increasing Diversity and Equity in Contemplative Neuroscience. Front Psychol. 2020; 11:631816.
Corrigendum: Toward a Compassionate Intersectional Neuroscience: Increasing Diversity and Equity in Contemplative Neuroscience.
Chang CC, Naranbhai V, Stern J, Roche M, Dantanarayana A, Ke R, Tennakoon S, Solomon A, Hoh R, Hartogensis W, Hecht FM, Sikaris K, Price DJ, Elliott JH, Deeks SG, Churchill M, Cameron PU, Hengartner N, Perelson AS, Lewin SR
Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1. AIDS. 2018 09 24; 32(15):2119-2128.
Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1.
Horsburgh BA, Hiener B, Fisher K, Lee E, Morgan H, Eden JS, von Stockenstrom S, Odevall L, Milush JM, Hoh R, Fromentin R, Chomont N, Hecht FM, Schlub TE, Deeks SG, Palmer S
Cellular Activation, Differentiation, and Proliferation Influence the Dynamics of Genetically Intact Proviruses Over Time. J Infect Dis. 2022 04 01; 225(7):1168-1178.
Cellular Activation, Differentiation, and Proliferation Influence the Dynamics of Genetically Intact Proviruses Over Time.
Fajnzylber J, Sharaf R, Hutchinson JN, Aga E, Bosch RJ, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest DJ, Margolis D, Sneller MC, Little SJ, Gulick RM, Mellors JW, Gandhi RT, Schooley RT, Henry K, Tebas P, Deeks S, Chun TW, Collier AC, Hecht FM, Li JZ, CHAMP study team
Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria. AIDS. 2021 11 01; 35(13):2225-2227.
Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria.
JAMA: Interest in the Ketogenic Diet Grows for Weight Loss and Type 2 Diabetes
Changing Environment Affects Stress Level in Mice
Wang P, Hecht F, Ossato G, Tille S, Fraser SE, Junge JA
Complex wavelet filter improves FLIM phasors for photon starved imaging experiments. Biomed Opt Express. 2021 Jun 01; 12(6):3463-3473.
Complex wavelet filter improves FLIM phasors for photon starved imaging experiments.
Optimizing an integrated whole-body hyperthermia and behavioral intervention for major depressive disorder
Jake-Schoffman DE, Brown SD, Baiocchi M, Bibeau JL, Daubenmier J, Ferrara A, Galarce MN, Hartogensis W, Hecht FM, Hedderson MM, Moran PJ, Pagoto SL, Tsai AL, Waring ME, Kiernan M
Methods-Motivational Interviewing Approach for Enhanced Retention and Attendance. Am J Prev Med. 2021 10; 61(4):606-617.
Methods-Motivational Interviewing Approach for Enhanced Retention and Attendance.
Morcilla V, Bacchus-Souffan C, Fisher K, Horsburgh BA, Hiener B, Wang XQ, Schlub TE, Fitch M, Hoh R, Hecht FM, Martin JN, Deeks SG, Hellerstein MK, McCune JM, Hunt PW, Palmer S
HIV-1 Genomes Are Enriched in Memory CD4+ T-Cells with Short Half-Lives. mBio. 2021 10 26; 12(5):e0244721.
HIV-1 Genomes Are Enriched in Memory CD4+ T-Cells with Short Half-Lives.
HIV/AIDS, Non-communicable diseases, Infectious disease, Immunization & immunology, Tuberculosis, Uganda, IGHS - Affiliate Program
{"interests":["HIV/AIDS","Non-communicable diseases","Infectious disease","Immunization & immunology","Tuberculosis"],"locations": ["Uganda"],"centers": ["IGHS - Affiliate Program"]}
Infectious disease, HIV/AIDS, Epidemiology & surveillance, Tuberculosis, Education, Immunization & immunology, Malaria, Newborn & infant health, Child & adolescent health, Pharmacology, Botswana, Brazil, China, Haiti, India, Cote d'Ivoire, Kenya, Malawi, South Africa, Zimbabwe, IGHS - Affiliate Program
{"interests":["Infectious disease","HIV/AIDS","Epidemiology & surveillance","Tuberculosis","Education","Immunization & immunology","Malaria","Newborn & infant health","Child & adolescent health","Pharmacology"],"locations": ["Botswana","Brazil","China","Haiti","India","Cote d'Ivoire","Kenya","Malawi","South Africa","Zimbabwe"],"centers": ["IGHS - Affiliate Program"]}
Stern J, Solomon A, Dantanarayana A, Pascoe R, Reynaldi A, Davenport MP, Milush J, Deeks SG, Hartogensis W, Hecht FM, Cockerham L, Roche M, Lewin SR
Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral Therapy. J Infect Dis. 2022 05 16; 225(10):1721-1730.
Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral Therapy.
Namazi G, Fajnzylber JM, Aga E, Bosch RJ, Acosta EP, Sharaf R, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest D, Margolis D, Sneller MC, Little SJ, Gianella S, Smith DM, Kuritzkes DR, Gulick RM, Mellors JW, Mehraj V, Gandhi RT, Mitsuyasu R, Schooley RT, Henry K, Tebas P, Deeks SG, Chun TW, Collier AC, Routy JP, Hecht FM, Walker BD, Li JZ
The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis. 2018 11 05; 218(12):1954-1963.
The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies.
Volek JS, Phinney SD, Krauss RM, Johnson RJ, Saslow LR, Gower B, Yancy WS, King JC, Hecht FM, Teicholz N, Bistrian BR, Hamdy O
Alternative Dietary Patterns for Americans: Low-Carbohydrate Diets. Nutrients. 2021 Sep 22; 13(10).
Alternative Dietary Patterns for Americans: Low-Carbohydrate Diets.
Van Blarigan EL, Dhruva A, Atreya CE, Kenfield SA, Chan JM, Milloy A, Kim I, Steiding P, Laffan A, Zhang L, Piawah S, Fukuoka Y, Miaskowski C, Hecht FM, Kim MO, Venook AP, Van Loon K
Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II). JMIR Cancer. 2022 Jan 11; 8(1):e31576.
Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II).
Lebares CC, Braun HJ, Guvva EV, Epel ES, Hecht FM
Burnout and gender in surgical training: A call to re-evaluate coping and dysfunction. Am J Surg. 2018 10; 216(4):800-804.
Burnout and gender in surgical training: A call to re-evaluate coping and dysfunction.
Mason AE, Kasl P, Hartogensis W, Natale JL, Dilchert S, Dasgupta S, Purawat S, Chowdhary A, Anglo C, Veasna D, Pandya LS, Fox LM, Puldon KY, Prather JG, Gupta A, Altintas I, Smarr BL, Hecht FM
Metrics from Wearable Devices as Candidate Predictors of Antibody Response Following Vaccination against COVID-19: Data from the Second TemPredict Study. Vaccines (Basel). 2022 Feb 09; 10(2).
Metrics from Wearable Devices as Candidate Predictors of Antibody Response Following Vaccination against COVID-19: Data from the Second TemPredict Study.
Mason AE, Hecht FM, Davis SK, Natale JL, Hartogensis W, Damaso N, Claypool KT, Dilchert S, Dasgupta S, Purawat S, Viswanath VK, Klein A, Chowdhary A, Fisher SM, Anglo C, Puldon KY, Veasna D, Prather JG, Pandya LS, Fox LM, Busch M, Giordano C, Mercado BK, Song J, Jaimes R, Baum BS, Telfer BA, Philipson CW, Collins PP, Rao AA, Wang EJ, Bandi RH, Choe BJ, Epel ES, Epstein SK, Krasnoff JB, Lee MB, Lee SW, Lopez GM, Mehta A, Melville LD, Moon TS, Mujica-Parodi LR, Noel KM, Orosco MA, Rideout JM, Robishaw JD, Rodriguez RM, Shah KH, Siegal JH, Gupta A, Altintas I, Smarr BL
Detection of COVID-19 using multimodal data from a wearable device: results from the first TemPredict Study. Sci Rep. 2022 03 02; 12(1):3463.
Detection of COVID-19 using multimodal data from a wearable device: results from the first TemPredict Study.
Dragomanovich HM, Dhruva A, Ekman E, Schoenbeck KL, Kubo A, Van Blarigan EL, Borno HT, Esquivel M, Chee B, Campanella M, Philip EJ, Rettger JP, Rosenthal B, Van Loon K, Venook AP, Boscardin C, Moran P, Hecht FM, Atreya CE
Being Present 2.0: Online Mindfulness-Based Program for Metastatic Gastrointestinal Cancer Patients and Caregivers. Glob Adv Health Med. 2021; 10:21649561211044693.
Being Present 2.0: Online Mindfulness-Based Program for Metastatic Gastrointestinal Cancer Patients and Caregivers.
Author Correction: Feasibility of continuous fever monitoring using wearable devices. Sci Rep. 2022 Mar 15; 12(1):4427.
Author Correction: Feasibility of continuous fever monitoring using wearable devices.
Felder JN, Mirchandaney R, Harrison J, Manber R, Cuneo J, Krystal A, Epel E, Hecht F
Examining Experiences of Poor Sleep During Pregnancy: A Qualitative Study to Inform the Development of a Prenatal Sleep Intervention. Glob Adv Health Med. 2022; 11:2164957X221087655.
Examining Experiences of Poor Sleep During Pregnancy: A Qualitative Study to Inform the Development of a Prenatal Sleep Intervention.
Author Correction: Detection of COVID-19 using multimodal data from a wearable device: results from the first TemPredict Study. Sci Rep. 2022 Mar 16; 12(1):4568.
Author Correction: Detection of COVID-19 using multimodal data from a wearable device: results from the first TemPredict Study.
Diane Havlir: SEARCHing for the End of AIDS San Francisco’s bold AIDS mission is ‘getting to zero’ by 2030 How a remote Kenyan island is helping create world-class HIV care Waging The War On AIDS: A Battle High-Tech and Low
Academic Senate’s Faculty Research Lecture in Clinical Science Awarded to Diane Havlir, MD Diane Havlir: SEARCHing for the End of AIDS San Francisco’s bold AIDS mission is ‘getting to zero’ by 2030 How a remote Kenyan island is helping create world-class HIV care Waging The War On AIDS: A Battle High-Tech and Low I Brainstorm Health I Fortune The Epidemiology, Science & Clinical Manifestations of COVID-19: A UCSF Update
The State of HIV: Where we are now and where are we going with Dr. Diane Havlir Academic Senate’s Faculty Research Lecture in Clinical Science Awarded to Diane Havlir, MD Diane Havlir: SEARCHing for the End of AIDS San Francisco’s bold AIDS mission is ‘getting to zero’ by 2030 How a remote Kenyan island is helping create world-class HIV care Waging The War On AIDS: A Battle High-Tech and Low I Brainstorm Health I Fortune The Epidemiology, Science & Clinical Manifestations of COVID-19: A UCSF Update
Community Matters: UCSF And The Bay Area's Fight Against COVID-19 The State of HIV: Where we are now and where are we going with Dr. Diane Havlir Academic Senate’s Faculty Research Lecture in Clinical Science Awarded to Diane Havlir, MD Diane Havlir: SEARCHing for the End of AIDS San Francisco’s bold AIDS mission is ‘getting to zero’ by 2030 How a remote Kenyan island is helping create world-class HIV care Waging The War On AIDS: A Battle High-Tech and Low I Brainstorm Health I Fortune The Epidemiology, Science & Clinical Manifestations of COVID-19: A UCSF Update
[{"name":"Diane Havlir: SEARCHing for the End of AIDS","youTubeId":"RZjFS7iGOKo","url":"https://www.youtube.com/watch?v=RZjFS7iGOKo"},{"name":"San Francisco’s bold AIDS mission is ‘getting to zero’ by 2030","youTubeId":"J5m0VEcJux0","url":"https://www.youtube.com/watch?v=J5m0VEcJux0"},{"name":"How a remote Kenyan island is helping create world-class HIV care","youTubeId":"KGBRm9MJDwY","url":"https://www.youtube.com/watch?v=KGBRm9MJDwY"},{"name":"Waging The War On AIDS: A Battle High-Tech and Low","youTubeId":"Qb2gYKV36zY","url":"https://www.youtube.com/watch?v=Qb2gYKV36zY"},{"name":"The Epidemiology, Science & Clinical Manifestations of COVID-19: A UCSF Update from UCSF Medical Grand Rounds","youTubeId":"UdUci2Y9QB8","url":"https://youtu.be/UdUci2Y9QB8"}]
[ { "url": "https://www.youtube.com/watch?v=0tuKo-i7CcE", "title": "Academic Senate’s Faculty Research Lecture in Clinical Science Awarded to Diane Havlir, MD", "thumbnail_url": "https://i.ytimg.com/vi/0tuKo-i7CcE/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=RZjFS7iGOKo", "title": "Diane Havlir: SEARCHing for the End of AIDS", "thumbnail_url": "https://i.ytimg.com/vi/RZjFS7iGOKo/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=J5m0VEcJux0", "title": "San Francisco’s bold AIDS mission is ‘getting to zero’ by 2030", "thumbnail_url": "https://i.ytimg.com/vi/J5m0VEcJux0/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=KGBRm9MJDwY", "title": "How a remote Kenyan island is helping create world-class HIV care", "thumbnail_url": "https://i.ytimg.com/vi/KGBRm9MJDwY/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=Qb2gYKV36zY", "title": "Waging The War On AIDS: A Battle High-Tech and Low I Brainstorm Health I Fortune", "thumbnail_url": "https://i.ytimg.com/vi/Qb2gYKV36zY/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=UdUci2Y9QB8&feature=youtu.be", "title": "The Epidemiology, Science & Clinical Manifestations of COVID-19: A UCSF Update", "thumbnail_url": "https://i.ytimg.com/vi/UdUci2Y9QB8/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }]
[ { "url": "https://www.youtube.com/watch?v=F5Kk0QbX4D8", "title": "The State of HIV: Where we are now and where are we going with Dr. Diane Havlir", "thumbnail_url": "https://i.ytimg.com/vi/F5Kk0QbX4D8/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=0tuKo-i7CcE", "title": "Academic Senate’s Faculty Research Lecture in Clinical Science Awarded to Diane Havlir, MD", "thumbnail_url": "https://i.ytimg.com/vi/0tuKo-i7CcE/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=RZjFS7iGOKo", "title": "Diane Havlir: SEARCHing for the End of AIDS", "thumbnail_url": "https://i.ytimg.com/vi/RZjFS7iGOKo/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=J5m0VEcJux0", "title": "San Francisco’s bold AIDS mission is ‘getting to zero’ by 2030", "thumbnail_url": "https://i.ytimg.com/vi/J5m0VEcJux0/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=KGBRm9MJDwY", "title": "How a remote Kenyan island is helping create world-class HIV care", "thumbnail_url": "https://i.ytimg.com/vi/KGBRm9MJDwY/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=Qb2gYKV36zY", "title": "Waging The War On AIDS: A Battle High-Tech and Low I Brainstorm Health I Fortune", "thumbnail_url": "https://i.ytimg.com/vi/Qb2gYKV36zY/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=UdUci2Y9QB8&feature=youtu.be", "title": "The Epidemiology, Science & Clinical Manifestations of COVID-19: A UCSF Update", "thumbnail_url": "https://i.ytimg.com/vi/UdUci2Y9QB8/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }]
[ { "url": "https://www.youtube.com/watch?v=dABFHXuX-nI", "title": "Community Matters: UCSF And The Bay Area's Fight Against COVID-19", "thumbnail_url": "https://i.ytimg.com/vi/dABFHXuX-nI/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=F5Kk0QbX4D8", "title": "The State of HIV: Where we are now and where are we going with Dr. Diane Havlir", "thumbnail_url": "https://i.ytimg.com/vi/F5Kk0QbX4D8/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=0tuKo-i7CcE", "title": "Academic Senate’s Faculty Research Lecture in Clinical Science Awarded to Diane Havlir, MD", "thumbnail_url": "https://i.ytimg.com/vi/0tuKo-i7CcE/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=RZjFS7iGOKo", "title": "Diane Havlir: SEARCHing for the End of AIDS", "thumbnail_url": "https://i.ytimg.com/vi/RZjFS7iGOKo/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=J5m0VEcJux0", "title": "San Francisco’s bold AIDS mission is ‘getting to zero’ by 2030", "thumbnail_url": "https://i.ytimg.com/vi/J5m0VEcJux0/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=KGBRm9MJDwY", "title": "How a remote Kenyan island is helping create world-class HIV care", "thumbnail_url": "https://i.ytimg.com/vi/KGBRm9MJDwY/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=Qb2gYKV36zY", "title": "Waging The War On AIDS: A Battle High-Tech and Low I Brainstorm Health I Fortune", "thumbnail_url": "https://i.ytimg.com/vi/Qb2gYKV36zY/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }, { "url": "https://www.youtube.com/watch?v=UdUci2Y9QB8&feature=youtu.be", "title": "The Epidemiology, Science & Clinical Manifestations of COVID-19: A UCSF Update", "thumbnail_url": "https://i.ytimg.com/vi/UdUci2Y9QB8/hqdefault.jpg", "html": " ", "updated": "2024-07-30" }]
Emotions, Stress, and Rate of Telomere Shortening: Are Our Cells Listening to Us? The Science of Stress (NIH OBSSR) IOM 2015 meeting (aging society) TEDMED (starts at minute 5:45)
The Science of Stress (NIH OBSSR) IOM 2015 meeting (aging society) TEDMED (starts at minute 5:45)
Healthy Longevity, happiness, and cell aging The Science of Stress (NIH OBSSR) IOM 2015 meeting (aging society) TEDMED (starts at minute 5:45)
[{"name":"Emotions, Stress, and Rate of Telomere Shortening: Are Our Cells Listening to Us?","youTubeId":"NB_zt96UiUY","url":"http://www.uctv.tv/shows/23204"},{"name":"The Science of Stress (NIH OBSSR)","youTubeId":"bZA5Y10uuBM","url":"https://www.youtube.com/watch?v=bZA5Y10uuBM"},{"name":"IOM 2015 meeting (aging society)","youTubeId":"4H7twfpJSnk","url":"https://www.youtube.com/watch?v=4H7twfpJSnk"},{"name":"TEDMED (starts at minute 5:45)","youTubeId":"mnMuuRcczf8","url":"https://www.youtube.com/watch?v=mnMuuRcczf8"}]
[ { "name": "The Science of Stress (NIH OBSSR)", "url": "https://www.youtube.com/watch?v=bZA5Y10uuBM", "youTubeId": "bZA5Y10uuBM" }, { "name": "IOM 2015 meeting (aging society)", "url": "https://www.youtube.com/watch?v=4H7twfpJSnk", "youTubeId": "4H7twfpJSnk" }, { "name": "TEDMED (starts at minute 5:45)", "url": "https://www.youtube.com/watch?v=mnMuuRcczf8", "youTubeId": "mnMuuRcczf8" }]
[ { "name": "Healthy Longevity, happiness, and cell aging", "url": "https://www.youtube.com/watch?v=94yKRVBwLj8", "youTubeId": "94yKRVBwLj8" }, { "name": "The Science of Stress (NIH OBSSR)", "url": "https://www.youtube.com/watch?v=bZA5Y10uuBM", "youTubeId": "bZA5Y10uuBM" }, { "name": "IOM 2015 meeting (aging society)", "url": "https://www.youtube.com/watch?v=4H7twfpJSnk", "youTubeId": "4H7twfpJSnk" }, { "name": "TEDMED (starts at minute 5:45)", "url": "https://www.youtube.com/watch?v=mnMuuRcczf8", "youTubeId": "mnMuuRcczf8" }]
Macronutrients and Metabolic Health What Do We Really Know About Meditation and Health?
[{"name":"Macronutrients and Metabolic Health","youTubeId":"oHew7Cw0LuU","url":"https://www.youtube.com/watch?v=oHew7Cw0LuU"},{"name":"What Do We Really Know About Meditation and Health?","youTubeId":"L3kl4GXHet8","url":"https://www.youtube.com/watch?v=L3kl4GXHet8"}]
Intervention Integrity in Mindfulness-Based Research. Mindfulness (N Y). 2018; 9(5):1370-1380.
Intervention Integrity in Mindfulness-Based Research.
Mason AE, Saslow L, Moran PJ, Kim S, Wali PK, Abousleiman H, Hartman A, Richler R, Schleicher S, Hartogensis W, Epel ES, Hecht F
Examining the Effects of Mindful Eating Training on Adherence to a Carbohydrate-Restricted Diet in Patients With Type 2 Diabetes (the DELISH Study): Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2019 02 20; 8(2):e11002.
Examining the Effects of Mindful Eating Training on Adherence to a Carbohydrate-Restricted Diet in Patients With Type 2 Diabetes (the DELISH Study): Protocol for a Randomized Controlled Trial.
Wedrychowski A, Martin HA, Li Y, Telwatte S, Kadiyala GN, Melberg M, Etemad B, Connick E, Jacobson JM, Margolis DM, Skiest D, Volberding P, Hecht F, Deeks S, Wong JK, Li JZ, Yukl SA
Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment Control. J Virol. 2023 01 31; 97(1):e0125422.
Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment Control.
Hooker AR, Sagui-Henson SJ, Daubenmier J, Moran PJ, Hartogensis W, Acree M, Kristeller J, Epel ES, Mason AE, Hecht FM
Effects of a Mindfulness-Based Weight Loss Intervention on Long-Term Psychological Well-Being Among Adults with Obesity: Secondary Analyses from the Supporting Health by Integrating Nutrition and Exercise (SHINE) Trial. Mindfulness (N Y). 2022 Sep; 13(9):2227-2242.
Effects of a Mindfulness-Based Weight Loss Intervention on Long-Term Psychological Well-Being Among Adults with Obesity: Secondary Analyses from the Supporting Health by Integrating Nutrition and Exercise (SHINE) Trial.
Siegel DA, Thanh C, Wan E, Hoh R, Hobbs K, Pan T, Gibson EA, Kroetz DL, Martin J, Hecht F, Pilcher C, Martin M, Carrington M, Pillai S, Busch MP, Stone M, Levy CN, Huang ML, Roychoudhury P, Hladik F, Jerome KR, Kiem HP, Henrich TJ, Deeks SG, Lee SA
Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size. AIDS. 2023 03 01; 37(3):477-488.
Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size.
Klein A, Puldon K, Dilchert S, Hartogensis W, Chowdhary A, Anglo C, Pandya LS, Hecht FM, Mason AE, Smarr BL
Methods for detecting probable COVID-19 cases from large-scale survey data also reveal probable sex differences in symptom profiles. Front Big Data. 2022; 5:1043704.
Methods for detecting probable COVID-19 cases from large-scale survey data also reveal probable sex differences in symptom profiles.
Dwivedi AK, Siegel DA, Thanh C, Hoh R, Hobbs KS, Pan T, Gibson EA, Martin J, Hecht F, Pilcher C, Milush J, Busch MP, Stone M, Huang ML, Levy CN, Roychoudhury P, Hladik F, Jerome KR, Henrich TJ, Deeks SG, Lee SA
bioRxiv : the preprint server for biology
Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infection. bioRxiv. 2023 Jan 12.
Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infection.
Fisher K, Schlub TE, Boyer Z, Rasmussen TA, Rhodes A, Hoh R, Hecht FM, Deeks SG, Lewin SR, Palmer S
Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4. Front Immunol. 2023; 14:1064346.
Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4.
Siwik CJ, Adler SR, Moran PJ, Kuyken W, Segal Z, Felder J, Eisendrath S, Hecht FM
Global advances in integrative medicine and health
Preventing Depression Relapse: A Qualitative Study on the Need for Additional Structured Support Following Mindfulness-Based Cognitive Therapy. Glob Adv Integr Med Health. 2023 Jan-Dec; 12:27536130221144247.
Preventing Depression Relapse: A Qualitative Study on the Need for Additional Structured Support Following Mindfulness-Based Cognitive Therapy.
Prather AA, Dutcher EG, Robinson J, Lin J, Blackburn E, Hecht FM, Mason AE, Fromer E, Merino B, Frazier R, O'Bryan J, Drury S, Epel ES
Predictors of long-term neutralizing antibody titers following COVID-19 vaccination by three vaccine types: the BOOST study. Sci Rep. 2023 05 09; 13(1):6505.
Predictors of long-term neutralizing antibody titers following COVID-19 vaccination by three vaccine types: the BOOST study.
Saslow LR, Missel AL, O'Brien A, Kim S, Hecht FM, Moskowitz JT, Bayandorian H, Pietrucha M, Raymond K, Richards B, Liestenfeltz B, Mason AE, Daubenmier J, Aikens JE
Psychological Support Strategies for Adults With Type 2 Diabetes in a Very Low-Carbohydrate Web-Based Program: Randomized Controlled Trial. JMIR Diabetes. 2023 May 11; 8:e44295.
Psychological Support Strategies for Adults With Type 2 Diabetes in a Very Low-Carbohydrate Web-Based Program: Randomized Controlled Trial.
Zaccaria A, Alimena G, Billström R, Carbonell F, Castoldi GL, Fuscaldo K, Gastaldi R, Hecht F, Mitelman F, Hossfeld DK
A cytogenetical analysis in patients with secondary hematological disorders. Haematologica. 1987 Nov-Dec; 72(6 Suppl):54-6.
A cytogenetical analysis in patients with secondary hematological disorders.
Floyd E, Adler SR, Crane RS, Brewer J, Moran P, Richler R, Hartogensis W, Kuyken W, Hecht FM
The Reliability of Rating via Audio-Recording Using the Mindfulness-Based Interventions: Teaching Assessment Criteria. Glob Adv Integr Med Health. 2023 Jan-Dec; 12:27536130221149966.
The Reliability of Rating via Audio-Recording Using the Mindfulness-Based Interventions: Teaching Assessment Criteria.
Saslow LR, Eslamian A, Moran P, Hartogensis W, Mason AE, Kim S, Bauer DC, Griauzde DH, Goldman V, Liu V, Stephens P, Raymond K, Yeung G, Leung C, Hecht FM
Protocol for a randomized controlled trial comparing a very low-carbohydrate diet or moderate-carbohydrate plate-method diet for type 2 diabetes: the LEGEND (Lifestyle Education about Nutrition for Diabetes) trial. Trials. 2023 Jul 20; 24(1):463.
Protocol for a randomized controlled trial comparing a very low-carbohydrate diet or moderate-carbohydrate plate-method diet for type 2 diabetes: the LEGEND (Lifestyle Education about Nutrition for Diabetes) trial.
Fromentin R, DaFonseca S, Costiniuk CT, El-Far M, Procopio FA, Hecht FM, Hoh R, Deeks SG, Hazuda DJ, Lewin SR, Routy JP, Sékaly RP, Chomont N
PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals. Nat Commun. 2019 02 18; 10(1):814.
PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals.
Reeves DB, Bacchus-Souffan C, Fitch M, Abdel-Mohsen M, Hoh R, Ahn H, Stone M, Hecht F, Martin J, Deeks SG, Hellerstein MK, McCune JM, Schiffer JT, Hunt PW
Estimating the contribution of CD4 T cell subset proliferation and differentiation to HIV persistence. Nat Commun. 2023 10 02; 14(1):6145.
Estimating the contribution of CD4 T cell subset proliferation and differentiation to HIV persistence.
Dutcher EG, Epel ES, Mason AE, Hecht FM, Robinson JE, Drury SS, Prather AA
medRxiv : the preprint server for health sciences
The more symptoms the better? Covid-19 vaccine side effects and long-term neutralizing antibody response. medRxiv. 2023 Nov 03.
The more symptoms the better? Covid-19 vaccine side effects and long-term neutralizing antibody response.
Bruce LK, Kasl P, Soltani S, Viswanath VK, Hartogensis W, Dilchert S, Hecht FM, Chowdhary A, Anglo C, Pandya L, Dasgupta S, Altintas I, Gupta A, Mason AE, Smarr BL
Variability of temperature measurements recorded by a wearable device by biological sex. Biol Sex Differ. 2023 11 01; 14(1):76.
Variability of temperature measurements recorded by a wearable device by biological sex.
Correction: Variability of temperature measurements recorded by a wearable device by biological sex. Biol Sex Differ. 2023 Nov 13; 14(1):82.
Correction: Variability of temperature measurements recorded by a wearable device by biological sex.
Dwivedi AK, Gornalusse GG, Siegel DA, Barbehenn A, Thanh C, Hoh R, Hobbs KS, Pan T, Gibson EA, Martin J, Hecht F, Pilcher C, Milush J, Busch MP, Stone M, Huang ML, Reppetti J, Vo PM, Levy CN, Roychoudhury P, Jerome KR, Hladik F, Henrich TJ, Deeks SG, Lee SA
A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size. PLoS Pathog. 2023 11; 19(11):e1011114.
A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size.
Sedentary Behavior and Dementia. JAMA. 2024 02 06; 331(5):442-443.
Mason AE, Kasl P, Soltani S, Green A, Hartogensis W, Dilchert S, Chowdhary A, Pandya LS, Siwik CJ, Foster SL, Nyer M, Lowry CA, Raison CL, Hecht FM, Smarr BL
Elevated body temperature is associated with depressive symptoms: results from the TemPredict Study. Sci Rep. 2024 02 05; 14(1):1884.
Elevated body temperature is associated with depressive symptoms: results from the TemPredict Study.
Mentoring Faculty Career Development Faculty Research Faculty Research Projects
{"narrative":"","mentoringInterests":[{"mentee":"Faculty","type":"Career Development"},{"mentee":"Faculty","type":"Research"},{"mentee":"Faculty","type":"Research Projects"}]}
Volek JS, Yancy WS, Gower BA, Phinney SD, Slavin J, Koutnik AP, Hurn M, Spinner J, Cucuzzella M, Hecht FM
Expert consensus on nutrition and lower-carbohydrate diets: An evidence- and equity-based approach to dietary guidance. Front Nutr. 2024; 11:1376098.
Expert consensus on nutrition and lower-carbohydrate diets: An evidence- and equity-based approach to dietary guidance.
Kasl P, Keeler Bruce L, Hartogensis W, Dasgupta S, Pandya LS, Dilchert S, Hecht FM, Gupta A, Altintas I, Mason AE, Smarr BL
Utilizing Wearable Device Data for Syndromic Surveillance: A Fever Detection Approach. Sensors (Basel). 2024 Mar 12; 24(6).
Utilizing Wearable Device Data for Syndromic Surveillance: A Fever Detection Approach.
Barbehenn A, Shi L, Shao J, Hoh R, Hartig HM, Pae V, Sarvadhavabhatla S, Donaire S, Sheikhzadeh C, Milush J, Laird GM, Mathias M, Ritter K, Peluso MJ, Martin J, Hecht F, Pilcher C, Cohen SE, Buchbinder S, Havlir D, Gandhi M, Henrich TJ, Hatano H, Wang J, Deeks SG, Lee SA
Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV Disease. medRxiv. 2024 Aug 22.
Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV Disease.
Mason AE, Chowdhary A, Hartogensis W, Siwik CJ, Lupesko-Persky O, Pandya LS, Roberts S, Anglo C, Moran PJ, Nelson JC, Lowry CA, Patrick RP, Raison CL, Hecht FM
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Feasibility and acceptability of an integrated mind-body intervention for depression: whole-body hyperthermia (WBH) and cognitive behavioral therapy (CBT). Int J Hyperthermia. 2024; 41(1):2351459.
Feasibility and acceptability of an integrated mind-body intervention for depression: whole-body hyperthermia (WBH) and cognitive behavioral therapy (CBT).
COVID-19 Vaccine Side Effects and Long-Term Neutralizing Antibody Response : A Prospective Cohort Study. Ann Intern Med. 2024 Jul; 177(7):892-900.
COVID-19 Vaccine Side Effects and Long-Term Neutralizing Antibody Response : A Prospective Cohort Study.
Diarrhea and AIDS. Ann Intern Med. 1990 Nov 15; 113(10):804-5.
Author Correction: Elevated body temperature is associated with depressive symptoms: results from the TemPredict Study. Sci Rep. 2024 Apr 29; 14(1):9819.
Author Correction: Elevated body temperature is associated with depressive symptoms: results from the TemPredict Study.
Viswanath VK, Hartogenesis W, Dilchert S, Pandya L, Hecht FM, Mason AE, Wang EJ, Smarr BL
Five million nights: temporal dynamics in human sleep phenotypes. NPJ Digit Med. 2024 Jun 20; 7(1):150.
Five million nights: temporal dynamics in human sleep phenotypes.
Felder JN, Mirchandaney R, Manber R, Cuneo J, Krystal A, Solomon N, Janette S, Zhang L, Moran P, Mashash M, Epel E, Hecht FM
Feasibility and Acceptability of Mindfulness-based Stress Reduction and Prenatal Sleep Classes for Poor Prenatal Sleep Quality: Pilot Randomized Controlled Trial. Behav Sleep Med. 2024 Sep-Oct; 22(5):739-753.
Feasibility and Acceptability of Mindfulness-based Stress Reduction and Prenatal Sleep Classes for Poor Prenatal Sleep Quality: Pilot Randomized Controlled Trial.
Ryan JM, Navaneethan S, Damaso N, Dilchert S, Hartogensis W, Natale JL, Hecht FM, Mason AE, Smarr BL
Information theory reveals physiological manifestations of COVID-19 that correlate with symptom density of illness. Front Netw Physiol. 2024; 4:1211413.
Information theory reveals physiological manifestations of COVID-19 that correlate with symptom density of illness.
Chao MT, Schillinger D, Nguyen U, Santana T, Liu R, Gregorich S, Hecht FM
A Randomized Clinical Trial of Group Acupuncture for Painful Diabetic Neuropathy Among Diverse Safety Net Patients. Pain Med. 2019 11 01; 20(11):2292-2302.
A Randomized Clinical Trial of Group Acupuncture for Painful Diabetic Neuropathy Among Diverse Safety Net Patients.
Mehling WE, Strigo IA, Goldman V, Hartogensis W, Adler SR, Lotz J, Hecht FM
Mind your pain: A single-arm feasibility study to assess a smartphone-based interoceptive attention training for patients with chronic low back pain. PLoS One. 2024; 19(10):e0307690.
Mind your pain: A single-arm feasibility study to assess a smartphone-based interoceptive attention training for patients with chronic low back pain.
Hecht FM, Crane RS, Moran P, Kuyken W, Hartogensis W, Brewer J
A Validation Study of the Mindfulness-Based Interventions Teaching Assessment Criteria for Assessing Mindfulness-Based Intervention Teacher Skill: Inter-Rater Reliability and Predictive Validity. Glob Adv Integr Med Health. 2024 Jan-Dec; 13:27536130241275962.
A Validation Study of the Mindfulness-Based Interventions Teaching Assessment Criteria for Assessing Mindfulness-Based Intervention Teacher Skill: Inter-Rater Reliability and Predictive Validity.
Epel E, Laraia B, Coleman-Phox K, Leung C, Vieten C, Mellin L, Kristeller JL, Thomas M, Stotland N, Bush N, Lustig RH, Dallman M, Hecht FM, Adler N
International journal of behavioral medicine
Effects of a Mindfulness-Based Intervention on Distress, Weight Gain, and Glucose Control for Pregnant Low-Income Women: A Quasi-Experimental Trial Using the ORBIT Model. Int J Behav Med. 2019 Oct; 26(5):461-473.
Effects of a Mindfulness-Based Intervention on Distress, Weight Gain, and Glucose Control for Pregnant Low-Income Women: A Quasi-Experimental Trial Using the ORBIT Model.
Magombedze G, Vendrame E, SenGupta D, Geleziunas R, Little S, Smith D, Walker B, Routy JP, Hecht FM, Chun TW, Sneller M, Li JZ, Deeks SG, Peluso MJ
Early Viral Dynamics Predict Human Immunodeficiency Virus Posttreatment Control After Analytic Treatment Interruption. J Infect Dis. 2025 Feb 20; 231(2):e419-e428.
Early Viral Dynamics Predict Human Immunodeficiency Virus Posttreatment Control After Analytic Treatment Interruption.
Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV disease. Nat Commun. 2024 11 18; 15(1):9966.
Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV disease.
Wang Y, Gornalusse GG, Siegel DA, Barbehenn A, Hoh R, Martin J, Hecht F, Pilcher C, Semenova L, Murdoch DM, Margolis DM, Levy CN, Jerome KR, Rudin CD, Hladik F, Deeks SG, Lee SA, Browne EP
NF-κB dependent gene expression and plasma IL-1β, TNFα and GCSF drive transcriptomic diversity and CD4:CD8 ratio in people with HIV on ART. bioRxiv. 2025 Feb 14.
NF-κB dependent gene expression and plasma IL-1β, TNFα and GCSF drive transcriptomic diversity and CD4:CD8 ratio in people with HIV on ART.
Mehling WE, Brintz CE, Hartogensis W, Wolf C, Rogers K, Adler SR, Strigo IA, Hecht FM
Development and Initial Validation of Mindfulness-Based Pain Reduction (MBPR) in Patients With Chronic Low Back Pain. J Pain Res. 2025; 18:785-801.
Development and Initial Validation of Mindfulness-Based Pain Reduction (MBPR) in Patients With Chronic Low Back Pain.
Nielsen A, Tick H, Mao JJ, Hecht F, Consortium Pain Task Force
Academic Consortium for Integrative Medicine & Health Commentary to CMS; RE: National Coverage Analysis (NCA) Tracking Sheet for Acupuncture for Chronic Low Back Pain (CAG-00452N). Glob Adv Health Med. 2019; 8:2164956119857648.
Academic Consortium for Integrative Medicine & Health Commentary to CMS; RE: National Coverage Analysis (NCA) Tracking Sheet for Acupuncture for Chronic Low Back Pain (CAG-00452N).
University of California, San Francisco, Clinical epidemiology -general internal medicine
Clinical epidemiology -general internal medicine
Einstein-Montifiore Residency Program in Social Medicine
Einstein-Montifiore Residency Program in Social Medicine, Internal Medicine residency
Varner KJ, Keeler Bruce L, Soltani S, Hartogensis W, Dilchert S, Hecht FM, Chowdhary A, Pandya L, Dasgupta S, Altintas I, Gupta A, Mason AE, Smarr BL
Sex Differences in the Variability of Physical Activity Measurements Across Multiple Timescales Recorded by a Wearable Device: Observational Retrospective Cohort Study. J Med Internet Res. 2025 Apr 28; 27:e66231.
Sex Differences in the Variability of Physical Activity Measurements Across Multiple Timescales Recorded by a Wearable Device: Observational Retrospective Cohort Study.
Soltani S, Viswanath VK, Kasl P, Hartogensis W, Dilchert S, Hecht FM, Mason AE, Smarr BL
Testing the Impact of Intensive, Longitudinal Sampling on Assessments of Statistical Power and Effect Size Within a Heterogeneous Human Population: Natural Experiment Using Change in Heart Rate on Weekends as a Surrogate Intervention. J Med Internet Res. 2025 May 21; 27:e60284.
Testing the Impact of Intensive, Longitudinal Sampling on Assessments of Statistical Power and Effect Size Within a Heterogeneous Human Population: Natural Experiment Using Change in Heart Rate on Weekends as a Surrogate Intervention.
Tong S, Litwin SM, Epel ES, Lin J, Drury SS, Hecht FM, Robinson JE, Prather AA, Norton EB
COVID-19 mRNA or viral vector vaccine type and subject sex influence the SARS-CoV-2 T-cell response. Vaccine. 2025 Aug 13; 61:127420.
COVID-19 mRNA or viral vector vaccine type and subject sex influence the SARS-CoV-2 T-cell response.
Mason AE, Saslow LR, Moran PJ, Kim S, Abousleiman H, Richler R, Schleicher S, Goldman VM, Hartman A, Leung C, Hartogensis W, Hecht FM
Lipid findings from the Diabetes Education to Lower Insulin, Sugars, and Hunger (DELISH) Study. Nutr Metab (Lond). 2019; 16:58.
Lipid findings from the Diabetes Education to Lower Insulin, Sugars, and Hunger (DELISH) Study.
Lown EA, Banerjee A, Vittinghoff E, Dvorak CC, Hartogensis W, Melton A, Mangurian C, Hu H, Shear D, Adcock R, Morgan M, Golden C, Hecht FM
Acupressure to Reduce Treatment-Related Symptoms for Children With Cancer and Recipients of Hematopoietic Stem Cell Transplant: Protocol for a Randomized Controlled Trial. Glob Adv Health Med. 2019; 8:2164956119870444.
Acupressure to Reduce Treatment-Related Symptoms for Children With Cancer and Recipients of Hematopoietic Stem Cell Transplant: Protocol for a Randomized Controlled Trial.
Updates and Outlook for GAIMH. Glob Adv Integr Med Health. 2025 Jan-Dec; 14:27536130251347754.
Siwik CJ, Chowdhary A, Anglo C, Pandya L, Roberts S, Lupesko-Persky O, Moran P, Hartogensis W, Lowry CA, Raison CL, Patrick R, Hecht FM, Mason AE
Treating major depressive disorder with an integrated mind-body intervention: Whole-body hyperthermia and cognitive behavioral therapy, a case report. Adv Integr Med. 2025 Sep; 12(3).
Treating major depressive disorder with an integrated mind-body intervention: Whole-body hyperthermia and cognitive behavioral therapy, a case report.
Intervention Fidelity in Mindfulness-Based Research and Practice: Overview of the Special Collection and State of the Field. Glob Adv Integr Med Health. 2025 Jan-Dec; 14:27536130251349453.
Intervention Fidelity in Mindfulness-Based Research and Practice: Overview of the Special Collection and State of the Field.
Laraia BA, Adler NE, Coleman-Phox K, Vieten C, Mellin L, Kristeller JL, Thomas M, Stotland NE, Lustig RH, Dallman MF, Hecht FM, Bush NR, de Groat CL, Epel E
Novel Interventions to Reduce Stress and Overeating in Overweight Pregnant Women: A Feasibility Study. Matern Child Health J. 2018 05; 22(5):670-678.
Novel Interventions to Reduce Stress and Overeating in Overweight Pregnant Women: A Feasibility Study.
Saslow L, Mason AE, Kim S, Goldman V, Ploutz-Snyder R, Bayandorian H, Daubenmier J, Hecht FM, Moskowitz JT
Authors' Reply: Comment on "An Online Intervention Comparing a Very Low-Carbohydrate Ketogenic Diet and Lifestyle Recommendations Versus a Plate Method Diet in Overweight Individuals With Type 2 Diabetes: A Randomized Controlled Trial". J Med Internet Res. 2018 05 01; 20(5):e181.
Authors' Reply: Comment on "An Online Intervention Comparing a Very Low-Carbohydrate Ketogenic Diet and Lifestyle Recommendations Versus a Plate Method Diet in Overweight Individuals With Type 2 Diabetes: A Randomized Controlled Trial".
Lee E, Bacchetti P, Milush J, Shao W, Boritz E, Douek D, Fromentin R, Liegler T, Hoh R, Deeks SG, Hecht FM, Chomont N, Palmer S
Memory CD4 + T-Cells Expressing HLA-DR Contribute to HIV Persistence During Prolonged Antiretroviral Therapy. Front Microbiol. 2019; 10:2214.
Memory CD4 + T-Cells Expressing HLA-DR Contribute to HIV Persistence During Prolonged Antiretroviral Therapy.
Hu H, Shear D, Thakkar R, Thompson-Lastad A, Pinderhughes H, Hecht FM, Lown EA
Acupressure and Therapeutic Touch in Childhood Cancer to Promote Subjective and Intersubjective Experiences of Well-being During Curative Treatment. Glob Adv Health Med. 2019; 8:2164956119880143.
Acupressure and Therapeutic Touch in Childhood Cancer to Promote Subjective and Intersubjective Experiences of Well-being During Curative Treatment.
Siwik CJ, Harrison JM, Kuyken W, Segal Z, Moran PJ, Felder JN, Hartogensis W, Goldman V, Eisendrath S, Hecht FM, Adler SR
Mindfulness-Based Cognitive Therapy for Depression, Taking It Further (MBCT-D-TiF): An Assessment of an Intervention Development Study. Glob Adv Integr Med Health. 2025 Jan-Dec; 14:27536130251407681.
Mindfulness-Based Cognitive Therapy for Depression, Taking It Further (MBCT-D-TiF): An Assessment of an Intervention Development Study.
Montero-Marin J, Farley ER, Maloney S, Crane R, D'Alton P, Eldridge R, Giommi F, Griffith G, Hecht FM, Hinze V, Loucks EB, Strauss C, Taylor L, Baer R, Kuyken W
Participants' Perspective on the Competence of Mindfulness-Based Interventions Teaching: Development and Validation of the Mindfulness-Based Interventions-Participants' Assessment of Teaching (MBI:PAT) Questionnaire. Mindfulness (N Y). 2025; 16(10):2825-2844.
Participants' Perspective on the Competence of Mindfulness-Based Interventions Teaching: Development and Validation of the Mindfulness-Based Interventions-Participants' Assessment of Teaching (MBI:PAT) Questionnaire.
A Review of Geroscience. JAMA. 2026 Feb 03; 335(5):460-461.
Mason AE, Hartogensis W, Chowdhary A, Siwik CJ, Pandya LS, Jung E, Lupesko-Persky O, Hartley E, Hopkins L, Roberts S, Borovinsky J, Nelson JC, Lowry CA, Patrick RP, Moran PJ, Raison CL, Hecht FM
A Randomized Trial Testing a Novel Mind and Body Intervention for Depression: Cognitive Behavioral Therapy (CBT) and Whole-Body Hyperthermia (WBH). Glob Adv Integr Med Health. 2025 Jan-Dec; 14:27536130251387714.
A Randomized Trial Testing a Novel Mind and Body Intervention for Depression: Cognitive Behavioral Therapy (CBT) and Whole-Body Hyperthermia (WBH).
Stern J, Roche M, Shepherd R, Hartogensis W, Moran P, Cockerham L, Saraya N, Rhodes A, Cameron PU, Chang JJ, Kumar N, Mendes WB, Deeks SG, Hecht FM, Lewin SR
The impact of acute stress on the HIV reservoir: a prospective interventional trial. J Virus Erad. 2025 Dec; 11(4):100613.
The impact of acute stress on the HIV reservoir: a prospective interventional trial.
Collaboration Interest, Academic Collaboration, Multicenter Clinical Research, Community and Partner Organizations,
{"collaborationInterests":["Academic Collaboration","Multicenter Clinical Research","Community and Partner Organizations"],"narrative":"","lastUpdated":"Friday October 15th, 2021"}
[{"Id":"NCT07226440","Title":"Examining a Novel Gastrointestinal Intervention to Negate Environmental Toxicants (ENGINE)","StartDate":"2026-03-01T00:00:00","EstimatedCompletionDate":"2028-12-31T00:00:00","CompletionDate":null,"Conditions":"Toxicant Exposure,Firefighter,Occupational Exposure to Chemicals","Status":"Recruiting","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.ucsf.edu/trial/NCT07226440"},{"Id":"NCT07223099","Title":"Sauna for Offline Connections and Interactive, Authentic Living","StartDate":"2026-01-03T00:00:00","EstimatedCompletionDate":"2026-12-30T00:00:00","CompletionDate":null,"Conditions":"Loneliness","Status":"Not yet recruiting","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.ucsf.edu/trial/NCT07223099"},{"Id":"NCT05708976","Title":"HypErthermia as an Additional Treatment for the Biology and Experience of Depression: Study 2","StartDate":"2023-02-15T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2024-09-30T00:00:00","Conditions":"Depression,Cognitive Behavioral Therapy","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT05708976"},{"Id":"NCT05041361","Title":"HypErthermia as an Additional Treatment for the Biology and Experience of Depression","StartDate":"2021-10-11T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2023-03-01T00:00:00","Conditions":"Depression,Cognitive Behavioral Therapy","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT05041361"},{"Id":"NCT04249700","Title":"Investigating the Effect of Single-session Sauna Use on Body Temperature","StartDate":"2019-09-13T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2020-04-01T00:00:00","Conditions":"Core Body Temperature 101.3 F","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT04249700"},{"Id":"NCT02805972","Title":"Biology and Experience of Eating in Women With Obesity","StartDate":"2017-05-20T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2018-07-25T00:00:00","Conditions":"Obesity,Bulimia","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT02805972"},{"Id":"NCT03207711","Title":"Delish Study: Diabetes Education to Lower Insulin, Sugars, and Hunger","StartDate":"2017-02-17T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2018-09-01T00:00:00","Conditions":"Diabetes,Diabetes Type 2,Mindfulness","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT03207711"},{"Id":"NCT02694731","Title":"A Mindfulness Mobile Intervention Targeting Reductions in Food Cravings","StartDate":"2016-02-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2016-11-30T00:00:00","Conditions":"Food Cravings,Mindfulness","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT02694731"},{"Id":"NCT02585336","Title":"Changes in Sugar-sweetened Beverage Intake and Metabolic Health: Improving Metabolic Profile Very Effortlessly","StartDate":"2015-07-28T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2016-10-16T00:00:00","Conditions":"Metabolic Health","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT02585336"}]
[{"Id":"NCT04840199","Title":"A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.","StartDate":"2022-04-19T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2023-11-30T00:00:00","Conditions":"HIV/AIDS,Cytomegalovirus,Immunodeficiency","Status":"Terminated","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT04840199"},{"Id":"NCT00735072","Title":"Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure","StartDate":"2008-09-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2010-07-31T00:00:00","Conditions":"HIV/AIDS,HIV-Associated Dementia","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT00735072"},{"Id":"NCT00264290","Title":"Valganciclovir to Reduce T Cell Activation in HIV Infection","StartDate":"2006-08-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2008-11-30T00:00:00","Conditions":"HIV/AIDS,Cytomegalovirus","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT00264290"}]
[{"Id":"NCT03315962","Title":"Simplified Isoniazid Preventive Therapy Strategy to Reduce TB Burden","StartDate":"2017-11-15T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2023-11-30T00:00:00","Conditions":"Tuberculosis,HIV/AIDS","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT03315962"},{"Id":"NCT03001128","Title":"Biomarkers to Predict Time to Plasma HIV RNA Rebound","StartDate":"2017-02-23T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2021-01-29T00:00:00","Conditions":"HIV/AIDS","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT03001128"},{"Id":"NCT01864603","Title":"Sustainable East Africa Research in Community Health","StartDate":"2013-04-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2021-04-01T00:00:00","Conditions":"HIV,Tuberculosis,Hypertension,Diabetes,Maternal Child Health,Cost Effectiveness","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT01864603"},{"Id":"NCT00884793","Title":"Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut","StartDate":"2008-09-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2010-12-31T00:00:00","Conditions":"HIV/AIDS","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT00884793"}]
[{"Id":"NCT00183261","Title":"Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection","StartDate":"2006-03-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2010-10-31T00:00:00","Conditions":"HIV/AIDS,Vaccine","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT00183261"},{"Id":"NCT00027339","Title":"Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV","StartDate":"2001-12-04T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2005-06-30T00:00:00","Conditions":"HIV/AIDS","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT00027339"}]
[{"Id":"NCT06810934","Title":"A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses","StartDate":"2025-10-21T00:00:00","EstimatedCompletionDate":"2029-10-31T00:00:00","CompletionDate":null,"Conditions":"COVID-19,Vaccine,RNA Virus Infections","Status":"Recruiting","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.ucsf.edu/trial/NCT06810934"},{"Id":"NCT04648046","Title":"CAR-T Cells for HIV Infection","StartDate":"2021-03-01T00:00:00","EstimatedCompletionDate":"2029-12-31T00:00:00","CompletionDate":null,"Conditions":"HIV/AIDS,Immunodeficiency","Status":"Recruiting","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.ucsf.edu/trial/NCT04648046"},{"Id":"NCT04359186","Title":"SCOPE Analytic Treatment Interruption Protocol","StartDate":"2020-10-15T00:00:00","EstimatedCompletionDate":"2028-06-30T00:00:00","CompletionDate":null,"Conditions":"HIV/AIDS,Immunodeficiency","Status":"Recruiting","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.ucsf.edu/trial/NCT04359186"},{"Id":"NCT04357821","Title":"Combinatorial Therapy to Induce an HIV Remission","StartDate":"2020-08-01T00:00:00","EstimatedCompletionDate":"2026-06-30T00:00:00","CompletionDate":null,"Conditions":"HIV/AIDS,Vaccine,Immunodeficiency","Status":"Active, not recruiting","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.ucsf.edu/trial/NCT04357821"},{"Id":"NCT04362150","Title":"Long-term Impact of Infection With Novel Coronavirus (COVID-19)","StartDate":"2020-04-21T00:00:00","EstimatedCompletionDate":"2030-12-31T00:00:00","CompletionDate":null,"Conditions":"COVID-19","Status":"Recruiting","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.ucsf.edu/trial/NCT04362150"},{"Id":"NCT03606213","Title":"Therapeutic Vaccination in Treated HIV Disease","StartDate":"2018-08-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2021-05-17T00:00:00","Conditions":"HIV/AIDS,HIV-Associated Dementia,Vaccine","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT03606213"},{"Id":"NCT01944371","Title":"Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study","StartDate":"2013-09-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2014-05-31T00:00:00","Conditions":"HIV/AIDS,Immunodeficiency","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT01944371"},{"Id":"NCT01202305","Title":"The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies","StartDate":"2011-04-01T00:00:00","EstimatedCompletionDate":"2030-04-30T00:00:00","CompletionDate":null,"Conditions":"HIV/AIDS","Status":"Recruiting","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.ucsf.edu/trial/NCT01202305"},{"Id":"NCT01286259","Title":"Short-term Disulfiram Administration to Accelerate the Decay of the HIV Reservoir in Antiretroviral-treated HIV Infected Individuals","StartDate":"2011-01-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2014-05-31T00:00:00","Conditions":"HIV/AIDS,HIV-Associated Dementia","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT01286259"},{"Id":"NCT01161199","Title":"The Use of Leukapheresis to Support HIV Pathogenesis Studies","StartDate":"2010-10-26T00:00:00","EstimatedCompletionDate":"2033-07-31T00:00:00","CompletionDate":null,"Conditions":"HIV/AIDS","Status":"Recruiting","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.ucsf.edu/trial/NCT01161199"},{"Id":"NCT00735072","Title":"Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure","StartDate":"2008-09-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2010-07-31T00:00:00","Conditions":"HIV/AIDS,HIV-Associated Dementia","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT00735072"},{"Id":"NCT00631449","Title":"Raltegravir Intensification in HIV-infected Patients","StartDate":"2008-02-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2010-03-31T00:00:00","Conditions":"HIV/AIDS,HIV-Associated Dementia","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT00631449"},{"Id":"NCT00053404","Title":"Immunologic Control of Drug Resistant HIV","StartDate":"2003-03-01T00:00:00","EstimatedCompletionDate":"2008-12-31T00:00:00","CompletionDate":null,"Conditions":"HIV/AIDS,HIV-Associated Dementia","Status":"Unknown status","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT00053404"},{"Id":"NCT00102934","Title":"Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus","StartDate":"2003-03-01T00:00:00","EstimatedCompletionDate":"2009-03-31T00:00:00","CompletionDate":null,"Conditions":"HIV/AIDS,HIV-Associated Dementia","Status":"Unknown status","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT00102934"},{"Id":"NCT00187551","Title":"Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance","StartDate":"2000-05-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2005-11-30T00:00:00","Conditions":"HIV/AIDS,Immunodeficiency","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT00187551"},{"Id":"NCT00187512","Title":"SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era","StartDate":"2000-03-01T00:00:00","EstimatedCompletionDate":"2033-12-31T00:00:00","CompletionDate":null,"Conditions":"HIV/AIDS","Status":"Recruiting","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.ucsf.edu/trial/NCT00187512"},{"Id":"NCT01336855","Title":"Collection of Blood for Multiple Collaborative Studies","StartDate":"1988-01-01T00:00:00","EstimatedCompletionDate":"2030-01-31T00:00:00","CompletionDate":null,"Conditions":"HIV/AIDS","Status":"Recruiting","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.ucsf.edu/trial/NCT01336855"}]
[{"Id":"NCT06528067","Title":"Mindful Motivation for Reducing Binge Eating","StartDate":"2024-08-01T00:00:00","EstimatedCompletionDate":"2026-09-30T00:00:00","CompletionDate":null,"Conditions":"Binge Eating Disorder,Health Behavior,Bulimia,Meditation","Status":"Active, not recruiting","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.ucsf.edu/trial/NCT06528067"},{"Id":"NCT05972109","Title":"Metabolic Health Improvement Program: Effects of a Workplace Sugary Beverages Sales Ban and Motivational Counseling","StartDate":"2023-08-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2026-02-01T00:00:00","Conditions":"Obesity,Insulin Resistance","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT05972109"},{"Id":"NCT04243694","Title":"Sustainable Mindfulness and Resilience Training (SMART)","StartDate":"2020-01-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2020-07-01T00:00:00","Conditions":"Caregivers,Autism,Mindfulness","Status":"Withdrawn","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT04243694"},{"Id":"NCT03945214","Title":"The Impact of 8 Weeks of Digital Meditation Application and Healthy Eating Program on Work Stress and Health Outcomes","StartDate":"2019-02-14T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2021-03-01T00:00:00","Conditions":"Mental Health,Stress,Behavioral Symptoms,Sleep,Health Behavior,Meditation,Nutrition","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT03945214"},{"Id":"NCT03837405","Title":"(R33 Phase) Delish Study: Diabetes Education to Lower Insulin, Sugars, and Hunger","StartDate":"2018-12-12T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2021-06-17T00:00:00","Conditions":"Diabetes,Diabetes Type 2,Mindfulness","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT03837405"},{"Id":"NCT03527303","Title":"The Impact of 8 Weeks of a Digital Meditation Application on Work Stress","StartDate":"2018-05-16T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2020-09-22T00:00:00","Conditions":"Mental Health,Stress,Behavioral Symptoms,Meditation","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT03527303"},{"Id":"NCT02585336","Title":"Changes in Sugar-sweetened Beverage Intake and Metabolic Health: Improving Metabolic Profile Very Effortlessly","StartDate":"2015-07-28T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2016-10-16T00:00:00","Conditions":"Metabolic Health","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT02585336"},{"Id":"NCT01993082","Title":"Fitness, Cellular Aging, and Caregiver Stress Study","StartDate":"2014-01-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2017-01-31T00:00:00","Conditions":"Mental Health,Stress,Disease Risk,Caregivers,Cardiovascular Disease","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT01993082"},{"Id":"NCT01959126","Title":"Health Enhancement And Resilience Training","StartDate":"2013-05-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2015-11-30T00:00:00","Conditions":"Mental Health,Stress,Well-being,Mindfulness","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT01959126"},{"Id":"NCT01307683","Title":"Maternal, Adiposity, Metabolism, and Stress Study","StartDate":"2011-08-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2015-12-31T00:00:00","Conditions":"Obesity,Gestational Weight Gain","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT01307683"},{"Id":"NCT01175512","Title":"Stress, Hormones, and Eating","StartDate":"2010-07-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2011-12-31T00:00:00","Conditions":"Food Addiction,How Opioid Tone Was Related to Self Reported,Drive to Eat Using a Measure of Food Addiction,Obesity","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT01175512"},{"Id":"NCT04104386","Title":"Telomere Disclosure and Impact on Psychological Distress and Health Behaviors","StartDate":"2010-04-04T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2011-11-15T00:00:00","Conditions":"Telomere Length, Mean Leukocyte","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT04104386"},{"Id":"NCT00960414","Title":"Randomized Controlled Clinical Trial of Weight Loss Programs in Obese Persons","StartDate":"2009-08-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2013-08-31T00:00:00","Conditions":"Obesity,Weight Loss,Metabolic Syndrome","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT00960414"},{"Id":"NCT00643344","Title":"Craving and Lifestyle Management Through Mindfulness Pilot Study","StartDate":"2008-01-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2008-12-31T00:00:00","Conditions":"Obesity,Mindfulness","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT00643344"},{"Id":"NCT01250509","Title":"Craving and Lifestyle Management Through Mindfulness Study","StartDate":"2006-11-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2008-07-31T00:00:00","Conditions":"Obesity,Mindfulness","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT01250509"}]
[{"Id":"NCT05859386","Title":"Optimizing Mindfulness Based Cognitive Therapy (MBCT) Maintenance","StartDate":"2023-04-03T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2024-02-19T00:00:00","Conditions":"Depression,Mindfulness","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT05859386"},{"Id":"NCT05708976","Title":"HypErthermia as an Additional Treatment for the Biology and Experience of Depression: Study 2","StartDate":"2023-02-15T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2024-09-30T00:00:00","Conditions":"Depression,Cognitive Behavioral Therapy","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT05708976"},{"Id":"NCT05041361","Title":"HypErthermia as an Additional Treatment for the Biology and Experience of Depression","StartDate":"2021-10-11T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2023-03-01T00:00:00","Conditions":"Depression,Cognitive Behavioral Therapy","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT05041361"},{"Id":"NCT03170167","Title":"Communitas: A Program for Teens Living With Chronic Illness and Their Families","StartDate":"2016-10-01T00:00:00","EstimatedCompletionDate":"2020-06-30T00:00:00","CompletionDate":null,"Conditions":"Chronic Illness","Status":"Unknown status","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT03170167"},{"Id":"NCT02895087","Title":"Study to Explore Natural Daily Variation and Impact of Stress in HIV Levels","StartDate":"2015-03-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2018-01-31T00:00:00","Conditions":"HIV/AIDS","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT02895087"},{"Id":"NCT01860261","Title":"Pilot Study of the Effects of Exercise on Aging Among Older Persons With HIV","StartDate":"2013-01-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2013-08-31T00:00:00","Conditions":"HIV/AIDS,Immunodeficiency","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT01860261"},{"Id":"NCT01713764","Title":"A Pilot Study of the Effects of Diet and Behavioral Interventions on Health in Diabetics","StartDate":"2012-10-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2013-11-30T00:00:00","Conditions":"Diabetes,Diabetes Type 2,Obesity,Mindfulness","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT01713764"},{"Id":"NCT00960414","Title":"Randomized Controlled Clinical Trial of Weight Loss Programs in Obese Persons","StartDate":"2009-08-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2013-08-31T00:00:00","Conditions":"Obesity,Weight Loss,Metabolic Syndrome","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT00960414"},{"Id":"NCT00643344","Title":"Craving and Lifestyle Management Through Mindfulness Pilot Study","StartDate":"2008-01-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2008-12-31T00:00:00","Conditions":"Obesity,Mindfulness","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT00643344"},{"Id":"NCT01250509","Title":"Craving and Lifestyle Management Through Mindfulness Study","StartDate":"2006-11-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2008-07-31T00:00:00","Conditions":"Obesity,Mindfulness","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT01250509"},{"Id":"NCT00271856","Title":"Staying Well: A Clinical Trial of Mindfulness-Based Stress Reduction and Education Groups for HIV","StartDate":"2005-05-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2009-09-30T00:00:00","Conditions":"HIV/AIDS,Mindfulness","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT00271856"},{"Id":"NCT00051766","Title":"Computer-Assisted Adherence Program for Patients Taking Anti-HIV Drugs","StartDate":"2003-01-16T00:00:00","EstimatedCompletionDate":null,"CompletionDate":null,"Conditions":"HIV/AIDS,Immunodeficiency,Treatment Adherence","Status":"Terminated","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT00051766"}]
[{"Id":"NCT04980612","Title":"Development and Feasibility of Mindfulness Based Pain Reduction","StartDate":"2021-12-14T00:00:00","EstimatedCompletionDate":"2025-12-01T00:00:00","CompletionDate":null,"Conditions":"Back Pain,Lower Back Pain,Pain,Mindfulness","Status":"Active, not recruiting","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.ucsf.edu/trial/NCT04980612"},{"Id":"NCT06186193","Title":"Mind Your Pain: Validating a Mindful Interoceptive Exposure Task for Patients With Chronic Low Back Pain","StartDate":"2021-05-21T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2023-07-21T00:00:00","Conditions":"Back Pain,Lower Back Pain,Pain","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT06186193"},{"Id":"NCT02403752","Title":"Paired Integrative Home Exercise for Seniors With Dementia and Their Caregivers (PairedPLIE)","StartDate":"2015-03-01T00:00:00","EstimatedCompletionDate":null,"CompletionDate":"2018-07-31T00:00:00","Conditions":"Dementia,Alzheimer's Disease,Caregivers","Status":"Completed","IsMultiSite":false,"SourceUrl":"https://clinicaltrials.gov/ct2/show/NCT02403752"}]
Lee E, von Stockenstrom S, Morcilla V, Odevall L, Hiener B, Shao W, Hartogensis W, Bacchetti P, Milush J, Liegler T, Sinclair E, Hatano H, Hoh R, Somsouk M, Hunt P, Boritz E, Douek D, Fromentin R, Chomont N, Deeks SG, Hecht FM, Palmer S
Impact of Antiretroviral Therapy Duration on HIV-1 Infection of T Cells within Anatomic Sites. J Virol. 2020 01 17; 94(3).
Impact of Antiretroviral Therapy Duration on HIV-1 Infection of T Cells within Anatomic Sites.
Radin RM, Epel ES, Daubenmier J, Moran P, Schleicher S, Kristeller J, Hecht FM, Mason AE
Health psychology : official journal of the Division of Health Psychology, American Psychological Association
Do stress eating or compulsive eating influence metabolic health in a mindfulness-based weight loss intervention? Health Psychol. 2020 Feb; 39(2):147-158.
Do stress eating or compulsive eating influence metabolic health in a mindfulness-based weight loss intervention?
Ketogenic Diets for Diabetes and Obesity. JAMA Intern Med. 2019 12 01; 179(12):1734.
Ketogenic Diets for Diabetes and Obesity.
Anderson JL, Khoury G, Fromentin R, Solomon A, Chomont N, Sinclair E, Milush JM, Hartogensis W, Bacchetti P, Roche M, Tumpach C, Gartner M, Pitman MC, Epling CL, Hoh R, Hecht FM, Somsouk M, Cameron PU, Deeks SG, Lewin SR
Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy. J Infect Dis. 2020 02 18; 221(5):744-755.
Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy.
2020 International Congress for Integrative Medicine and Health
Mason AE, Saslow LR, Moran PJ, Kim S, Wali PK, Abousleiman H, Richler R, Schleicher S, Goldman VM, Hartman A, Leung C, Hartogensis W, Hecht FM
Correction to: Lipid findings from the Diabetes Education to Lower Insulin, Sugars, and Hunger (DELISH) Study. Nutr Metab (Lond). 2019; 16:91.
Correction to: Lipid findings from the Diabetes Education to Lower Insulin, Sugars, and Hunger (DELISH) Study.
Horsburgh BA, Lee E, Hiener B, Eden JS, Schlub TE, von Stockenstrom S, Odevall L, Milush JM, Liegler T, Sinclair E, Hoh R, Boritz EA, Douek DC, Fromentin R, Chomont N, Deeks SG, Hecht FM, Palmer S
High levels of genetically intact HIV in HLA-DR+ memory T cells indicates their value for reservoir studies. AIDS. 2020 04 01; 34(5):659-668.
High levels of genetically intact HIV in HLA-DR+ memory T cells indicates their value for reservoir studies.
Correction: Examining the Effects of Mindful Eating Training on Adherence to a Carbohydrate-Restricted Diet in Patients With Type 2 Diabetes (the DELISH Study): Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020 Jan 13; 9(1):e17226.
Correction: Examining the Effects of Mindful Eating Training on Adherence to a Carbohydrate-Restricted Diet in Patients With Type 2 Diabetes (the DELISH Study): Protocol for a Randomized Controlled Trial.
University of California, Diversity, Equity, and Inclusion Champion Training
Diversity, Equity, and Inclusion Champion Training